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ABSTRACT 
 
This research is based on superimposing an alternating current (AC) onto a direct current 
(DC) during the nanopore analysis of various peptides, single-stranded DNA, α-synuclein (AS) 
protein, and AS-drug complexes.  Standard nanopore analysis consists of a constant DC voltage 
used to electrophoretically drive small molecules towards a pore.  The superposition of the AC 
voltage at constant amplitude and different frequencies causes small molecules to oscillate as 
they approach the pore vestibule which will lead to alterations of the event parameters, the 
blockade current and blockade time.  The DC voltage was set at 100 mV.  It was found that a 
200 mV AC voltage imposed over the DC voltage at frequencies from 10 MHz – 1 GHz was 
optimal to conduct the experiments.  Initially, four α-helical peptides with a Fmoc-capping 
group on the N-terminus with the general formula Fmoc-DDAxKK, were studied since their DC 
behaviour is well known, e.g. Fmoc-DDA10KK (A10), Fmoc-DDA14KK (A14), Fmoc-
DDA18KK (A18) and retro-inverse Fmoc-KKA10DD (RI-A10).  These peptides are of different 
length and consequently different dipole moments, which is hypothesised to alter their mobility 
in the AC field.  It was shown that the ratio of translocations to bumping events could be 
manipulated by a combination of AC voltage and frequencies.  In particular, A10 could be 
studied without interference from RI-A10.  Similarly, a large intrinsically disordered protein of 
140 amino acids, AS, which translocates the pore readily in a DC field could be prevented from 
doing so by application of an AC field of 200 mV at 100 MHz.  Additionally, three fragments 
of AS, C-terminal, N-terminal and the ΔNAC, were studied under the same AC conditions.  
After an AC field was applied, the C- and N-terminal were prevented from entering the pore 
due to their charge.  Conversely, ΔNAC behaved as expected for a peptide with a negative C-
terminus and/or with a large dipole moment, and the ratio of bumping events to translocation 
events, increased with an increase of the AC frequency.  Finally, nanopore analysis with an AC 
field was useful to probe the conformational states of AS which are induced by drugs.  Seven 
drugs were chosen to be studied in an AC field since their DC blockade histograms and binding 
properties are known. Five neuroprotective drugs (S-1-aminoindan, 3-methoxytyramine, 
caffeine, (-)-nicotine, metformin) and two neurotoxic drugs (cocaine and (+)-amphetamine) 
were studied.  Surprisingly, the neuroprotective AS-drug complexes, under the effect of the AC 
field, showed signs of drug stripping.  
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1. INTRODUCTION 
 
1.1 Introduction 
The focus of this research involves superimposing an AC field onto an already existing 
DC field during nanopore analysis of various analytes (Stefureac et al., 2012).  These include 
peptides, single-stranded DNA (ssDNA), α-synuclein (AS), and protein-drug complexes.  It 
was previously shown that the addition of an AC field in a nanopore setup helped with 
understanding the behaviour of the pore (Ervin et al., 2008; Keyser, 2011; Lathrop et al., 2010; 
Sigalov et al., 2008; Sujatha et al., 2010).  Recently published Molecular Dynamics (MDs) 
simulations have shown the strong influence that an AC field may have on the conformation of 
peptides and proteins (Astrakas et al., 2012; Budi et al., 2005; Toschi et al., 2009; Wang et al., 
2014).  The superposition of the AC voltage at a constant amplitude and different frequencies is 
presumed to cause the analytes to oscillate.  As an analyte approaches the pore, the oscillation 
will lead to alterations of the event parameters, the blockade current (I) and the blockade time 
(T) (Lamichhane et al., 2013).  
First, alpha-helical (α-helical) peptides with a fluorenylmethoxycarbonyl-capped group 
(Fmoc) on their N-termini, were studied because their electrophoretic DC behaviour is well 
documented (Chan and White, 2000; Perutz et al., 2002; Stefureac et al., 2006).  Furthermore, 
all of these peptides have stable secondary structures, are negatively charged and are known to 
have diverse dipole moments that will cause them to rotate and oscillate differently in the 
presence of an AC field.  A10 was initially studied in an AC field and was shown that the ration 
of bumping events increases with an increase of the AC frequency (Stefureac et al., 2012).  AC 
studies were also conducted with AS — the protein involved in Parkinson's disease (PD) — and 
its three domains: N-terminus, C-terminus, and the ΔNAC.  The behaviour of AS and its 
domains at an electrophoretic voltage of 100 mV has been previously investigated (Madampage 
et al., 2012; Tavassoly et al., 2014a).  AS is an intrinsically disordered protein with a large 
negative net charge which, presumably, will lead to fast oscillation in an AC field (Goedert, 
2001; Recchia et al., 2004; Ulmer et al., 2005).  As well, studies were performed to observe 
conformational changes in AS-drug complexes in response to an AC field.  Several drug 
analytes known to bind AS have been previously tested with nanopore analysis and isothermal 
titration calorimetry (ITC), and this information was useful in choosing the analytes for the 
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present study (Kakish et al., 2015a; Larkin et al., 2013; Tavassoly et al., 2014a; Tavassoly and 
Lee, 2012).  
To summarize, this thesis will focus on combining a constant AC amplitude with different 
AC frequencies (in the MHz range) to elucidate the performance of different analytes and the 
strength of the binding of various drugs.  This may help to develop a system that could explain 
the behaviour of analytes and complexes as they interact with the pore. 
 
1.2 Single molecule biosensors 
Nanopores are just one example of a biosensor.  In 1956, Leland C. Clark described the 
concept of a biosensor (Clark, 1956).  He discussed the development of an oxygen electrode 
(what is now called the Clark electrode) that would be inserted in the blood and tissue during 
cardiac surgery to observe and control the level of oxygenation.  Six years later he improved the 
biosensor concept by expanding the range of analytes that could be tested, but most importantly 
he demonstrated how to make these biosensors more specific.  The first biosensors were 
obtained by trapping glucose oxidase in a dialysis membrane on an oxygen electrode (Clark and 
Lyons, 1962).  Throughout the '70s, different authors worked on improving and increasing the 
diversity of biosensors by manufacturing electrochemical, pH, potentiometric or 
conductometric sensors (Palchetti and Mascini, 2010).   
Biosensors were manufactured and used in the '80s to observe the transport of different 
molecules through lipid membranes (Hall, 1986).  Generally, a biosensor is a biological tool 
used for the detection of an analyte in a biochemical or biophysical experiment, which consists 
of a receptor, a transducer and the reader (Hall, 1988; Turner et al., 1987).  The receptor is a 
biological component such as an antibody-antigen or enzyme-substrate incorporated and 
closely restrained in the transducer (Yamamoto et al., 1978).  The transducer itself is a sensing 
device capable of converting the biological event into a processable output that is shown in the 
reader (Cooper and Hall, 1988).  Biosensors have been designed and developed to work in vivo 
and in vitro and thus are ubiquitously used in cellular biochemistry and have revolutionized 
analytical technology (Koschwanez and Reichert, 2007; Notingher, 2007).  
Biosensors are used in many disciplines. In medicine, they monitor the levels of drugs, 
hormones, sugars, antibodies and proteins in the body fluids of patients (Lowe et al., 1981; 
Sibbald et al., 1984).  In industry, biosensors measure the levels of gas pollution, toxins, ions 
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and carbohydrates (Dorward and Barisas, 1984; Terry et al., 2005).  In agriculture, they control 
the levels of nutrients in plants grown hydroponically (Albery et al., 1985).  Biosensors have 
also been used for the detection of pesticides, herbicides and military poisons (Sassolas et al., 
2012).  Biosensors can be classified as molecular-, cellular- or tissue-based (Pancrazio et al., 
1999).  As shown in Figure 1, molecular biosensors make use of ion-selective channels, nucleic 
acids, antibodies and enzymes (Cheng et al., 1998; Cornell et al., 1997; Edman et al., 1997; 
Minami et al., 1991; Potyrailo et al., 1998).  
 
 
 
Figure 1.1 Types of cell-based potentiometric biosensors developed by incorporating 
different biological sensors at the gate of the Field Effect Transistor (FET). a. Ion-selective 
FET (ISFET); b. Enzyme sensor (ENZYMEFET) and c. Antibody-antigen binding sensor 
(IMMUNOFET). Reprinted and adopted with the permission from (Cooper and Hall, 1988). 
Copyright © 1988 Butterworth & Co (Publishers) Ltd. All rights reserved. 
 
Field Effect Transistors (FETs) are potentiometric sensors that convert biological 
reactions into electrical signals.  Some Ion Selective ISFETs, such as quadruple-gate chemical 
FET (CHEMFET), are used during surgery (Sibbald et al., 1984).  During a surgical procedure, 
biosensors measure the blood concentrations of Na
+
, K
+
, Ca
2+
 and H
+
 in real time. Today, 
CHEMFETs have reached the same status as ion-selective electrodes that can simultaneously 
4 
 
detect many cations and anions.  Some ISFETs are linked to an enzyme, but instead of 
measuring an enzymatic reaction, they measure cation levels.  For example, when cross-linking 
penicillinase to a pH-FET, the production of penicillin is able to be measured by calculating the 
levels of H
+
 (Caras and Janata, 1980).  In contrast, a pH-FET can also be linked to an enzyme, 
which is known as an ENZYMEFET, to measure the rate of an enzymatic reaction.  For 
example, incorporating the acetylcholinesterase enzyme into a pH-FET can enable the 
measuring of the direct levels of acetylcholine (Van der Schoot and Bergveld, 1988).  As shown 
in Figure 1.1, the principle of IMMUNOFETs is to attach an antibody to the surface of the 
sensor to cause changes in the ionic current intensity.  Two examples of IMMUNOFETs 
include a gate restrained anti-syphilis antibody and a gate restrained anti-albumin antibody on a 
FET sensor (Collins and Janata, 1982).  
Cell biosensors, on the other hand, are used mostly for environmental and pollutant 
screening with different whole-cell receptors being used for different analytes (Horn and Marty, 
1988).  Cell-based biosensors utilize microorganisms, especially Escherichia coli, to detect 
compounds such as formaldehydes and chenodeoxycholic acid (Belkin et al., 1997).  Cell 
fluorescence assays are used for high-throughput screening, especially in chemistry, biology 
and physics for qualitative distributions of subcellular proteins, nucleic acids and lipids  (Dunn 
et al., 1994); cell metabolism biosensors, such as eukaryotic cells and neurons, are used in 
measuring the extracellular pH (Owicki and Wallace Parce, 1992).  Intracellular and 
extracellular potential biosensors are used for monitoring cardiac impulses in different 
embryonic myocytes and estimating the levels of analytes, such as serotonin from the neurons 
of the visceral ganglion, in the common pond snail (Connolly et al., 1990; Skeen et al., 1990).  
Electrode impedance assays were used to monitor macrophages, endothelial cells, and 
fibroblasts (Kowolenko et al., 1990).  Finally, multichannel recordings are used for fast and 
nonspecific measurements of different dications, like Ca
2+
 and Mg
2+
, with multi-electrode 
arrays (Canepari et al., 1997).  While the whole-cell receptor brought new advantages, other 
problems appeared.  One problem with the multiple enzyme sensors was their lack of selectivity 
and specificity towards analytes (Pancrazio et al., 1999; Ziegler, 2000).  For example, the use of 
multiple enzyme layers on carbon nanotubes (CNTs) has been used to detect different proteins 
or DNA strands.  Recently, it was shown that such sensors attached on CNTs are able to detect 
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as few as 80 copies of DNA, but even though they are able to detect a small amount of DNA 
strands, they lack selectivity (Munge et al., 2005).  
Tissue-based biosensors are used for detecting and measuring hazardous organisms in the 
environment and hormones in the human body for medical research. (Acha et al., 2010).  As the 
name indicates they are based on a tissue that contains a protein that interacts with the analyte 
to be detected.  There are two types of tissue biosensors: the biosensor in which the protein 
sensor is incorporated directly into the tissue, and the biosensor in which the protein is 
expressed by means of initially inserting a gene into this tissue. (Pancrazio, 2001; Reininger-
Mack et al., 2002).  
While biosensors have a large number of advantages, their main one is in their 
inexpensive preparation (Nankai et al., 1992).  Additionally, some biosensors preserve their 
biological activity and can withstand buffer aggregation making them exceedingly reliable 
(Emregül, 2005).  They also give out real-time results without needing to be cleaned through an 
analytical procedure (Xu et al., 2009).  Furthermore, biosensors can be extremely selective and 
specific over a broad range of concentrations, and are able to resist decomposition, even after 
hours of experimentation (Haes and Van Duyne, 2002).  Finally, the detection schemes often do 
not require fluorescence or additional labelling (Huang et al., 2008; Lee et al., 2012).  
Biosensors also have considerable disadvantages when it comes to the use of FETs and 
ISFETs.  Such disadvantages include electrical noise, external contamination, solution leaking 
across the gates of the sensor, destabilization of biomolecules after many hours of running, as 
well as possible aggregation of the biosensor in aqueous solutions. Nevertheless, this 
technology is constantly improving as the collaboration of physical, biological and computer 
sciences continues to evolve. However, there are still major biological issues with this 
technology that need to be resolved, such as the stability and reproducibility of the ISFETs in 
vitro (Meusel and Vering, 1998).  
 
1.2.1 Cell membrane transporters 
The nanopores used in this thesis are examples of transporters that facilitate transport of 
analytes across the membrane (see Figure 1.2 a. facilitated diffusion).  Membrane transporters 
are based on two types of diffusion, down or against an electrochemical gradient.  A summary 
of the major types of  transporters is shown in Figure 1.2.     
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Figure 1.2 Summary of the different cell membrane transporters.  
 
A small number of molecules, mostly non-polar molecules, can move across the cell 
membrane without a membrane-bound facilitator or transporter.  Generally, transporters such as 
membrane proteins and/or ion channels facilitate the diffusion of larger, polar or charged 
molecules down their electrochemical gradients (Mulder, 1996). Glucose, sodium and 
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potassium ions are examples of molecules whose transport is facilitated across the cell 
membrane.  Transporters that move ions and molecules against their concentration and/or 
electrochemical gradients require energy. That is why this form of transportation is called 
"active" (Lennernäs et al., 1996).  Primary active transporters usually obtain their required 
energy for the movement of solutes from ATP hydrolysis, as in the case of the Na
+
/K
+
 and the 
proton-ATPase pumps, such as multiple drug resistance transporters.  Secondary active 
transporters obtain their required energy by transporting one analyte down its electrochemical 
gradient; the energy released by the transportation of this analyte is used to power another 
analyte to move against its electrochemical gradient.  These are classified as cotransporters 
which are divided into two groups: (a) symporter such as the Na
+
/glucose (both analytes are 
transported in the same direction) and (b) antiporter such as the Na
+
/Ca
2+
 (the analytes are 
counter-transported) (Gouaux and MacKinnon, 2005; Morth et al., 2011; Nelson et al., 2008). 
As mentioned, simple diffusion requires an ion-channel (Janshoff and Steinem, 2006; 
Kasianowicz et al., 1996).  Ion channels are transmembrane proteins with apertures that can be 
adjusted by a chemical, biochemical or electrical stimulus (Hille, 2001).  They were initially 
found in neurons.  These channels differ from ion pumps in three ways: (a) the ionic flux of 
these channels is greater than the flux of the pumps; (b) the ion channels cannot be saturated; 
and (c) these channels can be gated by aptamers, such as single-stranded RNA (ssRNA) and 
ssDNA molecules, or other ligands (Nelson et al., 2008).  Recently, simple channels have been 
co-opted to develop single molecule biosensors (Baaken et al., 2011; Jetha et al., 2009).  These 
single molecule biosensors are water-soluble polypeptides that self-assemble into a pore that 
has an internal diameter from 1 to 2 nm. Combining protein engineering, chemical modification 
and the ability to control the open pore via a voltage stimulus, these pores can be called target-
responsive biosensors (Bayley and Cremer, 2001). Due to their small scale that is measured in 
nanometers, these pores are called nanopores (Murray, 2008). There are many advantages to 
these analytic pores, including their ability to analyse small molecules. 
Overall, the focus of this thesis will be on biological pores used for analysis.  These pores 
are usually simple channels that allow facilitated diffusion of ions and other small molecules, 
such as nucleic acids, DNA fragments, peptide, small protein and protein/drug complexes down 
an electrochemical gradient. 
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1.3 Nanopore Technology 
Many methods are being developed for single molecule detection.  A major part of this 
technological growth is due to the ability to stabilize nanopores with new capabilities, 
functions, and properties involved in the detection and imaging of single-molecule sensing 
(Huang et al., 2007).  Nanopores are single-molecule Coulter counters a method invented by 
Coulter in the early 1950s, which consist of a nanometre aperture through an insulating 
membrane (Coulter, 1956).  Applying a voltage across this membrane results in an 
electrochemical gradient that drives ions through the nanopore (Bayley and Martin, 2000; 
Howorka and Siwy, 2009).  The use of these nanopores dates back nearly twenty years 
(Kasianowicz et al., 1996).  A variety of self-assembling bacterial pores and solid-state pores 
have been investigated, but perhaps the most popular of these is the α-hemolysin (α-HML) 
toxin derived from Staphylococcus aureus (Jetha et al., 2009).  This gave birth to a new method 
for detecting single molecules in a real-time screening technique known as nanopore analysis 
(Gu and Shim, 2010).  
 
1.3.1 Fundamentals of Nanopore analysis 
Nanopore analysis is a method that is influenced by environmental factors such as 
temperature and pressure, but it yields rapid, sensitive and reliable results (Cooper and Hall, 
1988).  The rapid results are due to the use of an immobilized device which is fitting for real-
time monitoring and analysis of different conformations (Branton et al., 2008). In contrast, 
techniques like Nuclear Magnetic Resonance (NMR) may not be suitable for studying multiple 
analyte conformations.  Similarly, X-ray crystallography cannot be used to study intrinsically 
disordered proteins.  Therefore, understanding the dynamics and folding of these analytes at a 
molecular level may only be possible using nanopore technology. The most important 
advantage of nanopore sensing is that molecules can be detected without labelling.  Uniquely, 
this technique requires less than an hour to non-destructively analyze thousands of single 
molecules (Wanunu et al., 2009).  
A lipid bilayer is stretched across a small opening that separates two chambers.  A pore is 
then inserted into the membrane and, upon application of a voltage, an ionic current (measured 
in picoampere (pA)) will be recorded.  Any large molecule, such as a peptide or a protein that 
interacts with the pore, will cause a drop in the current for a time, which is measured with a 
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patch clamp apparatus (Lamichhane et al., 2013).  In most cases, three types of events can be 
observed. The ideal case will have only translocations, but bumping and intercalation events are 
frequently encountered.  These events are shown in Figure 1.3: (a) Translocation events, where 
the analytes go through the pore, causing a large current blockade; (b) Intercalation events, 
where the analytes are trapped in the entrance of the pore, and will diffuse back after a period of 
time, causing an intermediate current blockade; and (c) Bumping events, where the molecules 
approach the pore, but then diffuse away without entering, causing a small current blockade 
(Christensen et al., 2011; Meng et al., 2010).   
Initially, this technology was applied to nucleic acids and has advanced to the level that 
rapid DNA sequencing with nanopores is now available (Schneider and Dekker, 2012). More 
recently, peptides and proteins have been studied (Mohammad and Movileanu, 2008; Stefureac 
et al., 2006).  The application of nanopore analysis for sequencing proteins may be decades 
away, but this technology has proved to be useful for studying protein folding.  For example, 
(a) Initial analysis of A-β peptides, which are deposited as amyloid plaques in Alzheimer 
disease (Zengin et al., 2013); (b) AS, which is implicated in Parkinson disease (Tavassoly et al., 
2014a); and (c) Prion proteins, which misfold in transmissible spongiform encephalopathy 
(Chiti and Dobson, 2006; Madampage et al., 2012).   
One disadvantage of alpha-hemolysin (α-HML) pores is that they have a small 
transmembrane opening of 1.5 nm and, thus, even small proteins will not translocate and often 
only give rise to bumping events.  Unfortunately, bumping events are very rapid with small 
blockade currents and result in very little discrimination between proteins (Simon and Blobel, 
1992).  In 2004, the Lee group published the first paper for nanopore-based peptide analysis 
(Sutherland et al., 2004).  It was shown that the peptide's structure was able to be studied with 
the help of α-HML.  Several peptides with a collagen-like sequence (G-P-G)n (n= 1 P1, n=2 P2, 
and n=3 P3) that were end labelled with ferrocene were analysed in the standard set up at 100 
mV DC.  The peptides with more collagen repeats were shown to give larger blockade currents 
and blockade times.  From the analysis of the blockade histograms and scatter plots, it was 
shown that nanopore analysis had the ability to differentiate these peptides based on their 
conformations (single, double and triple helix).  Since then, other pores have been investigated. 
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Figure 1.3 There are three possible types of events when a peptide interacts with α-HML 
pores. The AC voltage causes peptides to oscillate at the entrance of the pore.  
 
1.4 Structure of Alpha-Hemolysin and other protein pores 
Nanopores can be biological or synthetic.  Most of the pores used for biosensing are 
protein ion channels.  With a rigid conformation, these pores give reliable and repeatable 
results.  Several protein nanopores can be used in nanopore analysis, such as aerolysin (ARL) 
derived from Aeromonas hydrophila, ferric hydroxamate uptake component A (FhuA), 
Cytolysin A from Salmonella typhi (ClyA) or hetero-oligomeric pore from Nocardia farcinica 
porin A (NfpA) and porin B (NfpB).  Nevertheless, most of this work has been done using an α-
HML pore (Mohammad et al., 2012; Singh et al., 2012; Soskine et al., 2013).  For example, 
analytes such as collagen-like peptide, AS and mutants, β-Amyloids and barnase were analyzed 
with α-HML (Madampage et al., 2012; Mohammad et al., 2008; Sutherland et al., 2004; Wang 
et al., 2011). However, cationic peptides were analyzed with the NfpA and NfpB (Singh et al., 
2012).  Lysozyme, human thrombin, and bovine thrombin were analyzed with ClyA (Soskine et 
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al., 2012).  Lastly different lipids (e.g. 1-lauroyl-2-hydroxy-sn-glycero-3-phosphocholine) were 
analyzed with FhuA (Mohammad et al., 2012). 
Some of these protein pores have been modified via protein engineering for various uses 
in biochemistry and biotechnology (Bayley, 1997, 1999).  These modified pores could help 
detect molecules that cannot be analyzed with a standard nanopore and, thus, improve the 
detection levels of cytotoxic agents (Gu et al., 2001; Panchal et al., 1996).  In some cases, a 
receptor is attached in the lumen of the ion-channel via protein engineering or chemical 
adjustment.  For example, β-Cyclodextrin (βCB), a noncovalent molecular adapter, can be 
inserted into either the wild-type (WT) or mutant α-HML pore lumen (Bayley and Jayasinghe, 
2004; Gu and Bayley, 2000).  
α-HML is a self-assembling bio-pore that inserts into a lipid bilayer, giving a structure 
with reproducible dimensions and surface properties (Jetha et al., 2009).  α-HML derived from 
Staphylococcus aureus is a monomeric protein with a molecular mass of approximately 33 kDa 
and a length of 293 amino acids (Bayley, 1995).  It is soluble in water and also very toxic to 
mammalian erythrocytes, lymphocytes and endothelial cells (Bhakdi and Tranum-Jensen, 
1991).  The crystal structure of α-HML solved in the late 90's was revealed to be a heptameric 
transmembrane protein that resembles a mushroom (Gouaux, 1998; Song et al., 1996).  A more 
recent crystal structure was published January 2011 (Tanaka et al., 2011).  These two studies, 
revealed that each pore-forming monomer comes together seven times in a noncrystallographic 
axes (Galdiero and Gouaux, 2004).  Initially, the monomer is bound to the bilayer where a 
heptameric pre-pore is eventually formed.  Afterwards, a stem grows and penetrates the 
membrane bilayer, resulting in a membrane-bound heptameric pore (Aksimentiev and Schulten, 
2005; Montoya and Gouaux, 2003; Walker et al., 1992).   
The crystal structure, as shown in Figure 1.4, revealed that α-HML is composed of three 
domains: the cap (10 nm in outer diameter and cis-opening 2.6 nm), the rim (7 nm long and 3.7 
nm wide from the stem) and the stem (5.2 nm in height and diameter 2.6 nm with a trans-
opening around 2 nm) (Song et al., 1996).  The cap domain is surrounded by seven β-
sandwiches.  The rim domain, located below the cap, has four β-strands.  Lastly, the stem is 
constructed by fourteen antiparallel β-strands, which form a β-barrel (Tanaka et al., 2011).  The 
interior architecture is very interesting.  The channel through which the analytes pass varies in 
width.  It starts at 2.6 nm in the cis side opening, which is followed by a large 4.6 nm gap in the 
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vestibule and then by a narrow 1.5 nm region just after the vestibule.  The width of the stem is 
mostly constant at ~2 nm, but slightly larger at the end of the trans side, where it is 2.6 nm, 
similar to the cis side (DeGuzman et al., 2006; Wu et al., 2014).   
 
 
 
Figure 1.4 A. Side and B. Top view of α-HML in the lipid bilayer. C. and D. Cross section 
of the pore with the corresponding parameters of the vestibule, the rim and the stem. Reprinted 
and adapted with the permission from (Ma and Cockroft, 2010) Copyright © 2010 WILEY-
VCH Verlang GmbH & Co. KGaA, Weinheim. All rights reserved.  
 
α-HML, being a pore with reproducible dimensions and surface properties, is often used 
in nanopore analysis.  Under an applied DC voltage of 100 mV, each inserted channel has a 
current of 100 pA.  Once a pore is inserted, it can remain intact for hours in 1 M KCl.  The pore 
can operate within a wide pH-range (2 to 12), but optimal conductance levels, with negligible 
background noise, are obtained at pH values between 7.5 to 8 (Kasianowicz and Bezrukov, 
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1995).  The ionic current passing through the pore channel is detected with patch-clamp 
instruments.  The large vestibule helps analytes to orientate before they enter the pore.  The 
amino acids in the interior of the lumen (e.g. valine, isoleucine, leucine, phenylalanine, tyrosine 
and threonine) create a very hydrophobic environment, which facilitates the passage of anions 
and biological molecules (Song et al., 1996; Venkatesan and Bashir, 2011).  
An example of another self-assembling pore is ARL (Degiacomi et al., 2013; Howard and 
Buckley, 1986; Wilmsen et al., 1990).  Even though there is not yet a full crystal structure for 
the ARL pore, high-resolution Electron Microscopy (EM) has shown that the diameter of this 
pore is smaller than the α-HML pore as shown in Figure 1.5 and 1.6 (Parker et al., 1994).   
 
 
 
Figure 1.5 Graphic representation of the two bacterial pores inserted in a lipid bilayer while 
an α-helical peptide is passing through the stem of the pore. a. α-HML and b. ARL. Reprinted 
with the permission from (Stefureac et al., 2006). Copyright © 2006 American Chemical 
Society. All rights reserved. 
 
 
 
 
Figure 1.6 a. Schematic structure of the aerolysin stem. b. Top and side view from cryo-EM 
map of the 3D model of the heptameric pore. Reprinted with the permission from (Degiacomi 
et al., 2013) Copyright © 2013, Nature Publishing Group. All rights reserved. 
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The ARL pore lacks a vestibule, which in other pores may be helpful for aligning 
molecules towards the pore entrance.  Additionally, this pore has a smaller constriction and 
longer stem (see Figure 1.6), which makes this pore a poor choice for analyzing long and/or 
bulky analytes as a greater number of bumping events will be observed (Degiacomi et al., 2013; 
Moniatte et al., 1996).  Therefore the smaller open pore current of 50 pA for ARL is consistent 
with its smaller size compared to α-HML (Stefureac et al., 2006). 
Currently, there is another biological nanopore being investigated especially for DNA 
sequencing: Mycobacterium smegmatis porin A (MspA) (Faller et al., 2004).  As seen in Figure 
1.7, MspA is a 9.6 nm long pore that has an external diameter of 8.8 nm and a cis diameter of 
4.8 nm.  The pore may be more useful than α-HML because it has a much smaller vestibule, a 
thick rim and a 1.2 nm opening on the trans side of the pore. With such a larger diameter, 
MspA has a higher conductance than α-HML, ~4.9 nS for MspA and ~1 nS for α-HML in a 1 
M KCl solution, because the conductance is proportional to the square of the diameter.   
 
 
Figure 1.7 3D details of the outer surface (yellow = nonpolar region and green = polar 
region) of the MspA (panel 1) and its vestibule (panel 2) as well as a 1.9 times magnified 
version in atomic details of the pore vestibule. Reprinted and adopted with the permission from 
(Faller et al., 2004) Copyright © 2004 American Association for the Advancement of Science. 
All rights reserved. 
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In addition, even though the natural MspA looks very promising for DNA sequencing 
because of its shape and cis diameter, the negative charges at the constriction will prevent 
ssDNA from translocating (Manrao et al., 2011).  For this reason, MspA was modified into M1-
MspA, via protein engineering, to improve translocation.  Three negatively charged aspartic 
acids residues were replaced with neutral asparagines residues, to allow the translocation of 
ssDNA (Butler et al., 2008).  
Two other examples of nanopores include the glass membrane nanopore (GNP) (Figure 
1.8 a) and droplet interface bilayers (DIB) (Figure 1.8 b).  The GNP is supported over a lipid 
bilayer in an aqueous solution, whereas the DIB is formed in an oil solution (Bayley et al., 
2008).  Before the optimal GNP was produced there were a lot of problems with leakage from 
the glass surface (Fertig et al., 2002; White et al., 2007).  GNPs are fabricated by adhering a 
platinum wire in a glass capillary, which serves as the electrode, and smoothing the capillary 
until the platinum disk is in the nanometer range (Zhang et al., 2007).  The GNP was 
surrounded by 3-cyanopropyldimethylchlorosilane to create a hydrophobic surface; and  
afterwards, a second layer of lipids was painted on both the interior and exterior glass surfaces, 
forming an extraordinarily stable bilayer.  The bilayer is known to last up two weeks at room 
temperature and resists voltages up to 800 mV.  Furthermore, ion channels such as α-HML can 
uniquely be removed by applying a small pressure to the bilayer which will disrupt the stability 
of the membrane.  
In contrast, the DIB is a complex of two water droplets in a lipid suspension as shown in 
Figure 1.8 b (Funakoshi et al., 2006; Gu and Shim, 2010; Tsofina et al., 1966). It is 
manufactured by inserting a droplet of aqueous solution in the lipid phase, thus forming a layer 
of droplet-lipid interfaces.  Secondly, the two droplets are manufactured to communicate with 
each other and their lipids layers fuse into a bilayer on the interface, thus giving them the name 
droplet interface bilayers.  Lastly, different proteins channel are added to monitor analytes in 
the aqueous solution (Holden et al., 2007).    
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Figure 1.8 Other forms of nanopores. a. Inclusion of a biological pore in a lipid bilayer that 
is hanging over a glass nanopore. b. Droplet interface bilayer and its network. Reprinted and 
adapted with the permission from (Gu and Shim, 2010) Copyright © 2010 The Royal Society 
of Chemistry. All rights reserved. 
 
1.4.1 Other mutants of Alpha-Hemolysin 
The use of α-HML in nanopore analysis for certain analytes is limited due to the small cis 
opening, as well as the highly hydrophobic interior that acts as a barrier to bulky and/or polar 
molecules.  To improve translocation, one possible solution would be to mutate α-HML. To 
date, many successful mutants of α-HML have been made.  A different bioengineered version 
of α-HML was obtained by altering seven residues of methionine at the 113 position of the pore 
lumen to phenylalanine, M113F (Guan et al., 2005).  The new pore has aromatic side chains 
that interact with organic and aromatic molecules.  Additionally, this pore enhances the 
denaturation of short DNA duplexes (Gu and Bayley, 2000; Gu et al., 2001).  The military 
might find this altered version of the pore very useful in distinguishing 2,4,6-trinitrotoluene 
(TNT) from other nitroaromatic molecules on the basis of the event parameters.  This new way 
of stochastically detecting TNT, may also be useful for distinguishing hidden explosives and 
other terrorist agents (Guan et al., 2011; Guan et al., 2005).  Biochemists have found this 
mutated pore helpful to elucidate noncovalent interactions between aromatic molecules and to 
detect metal ions (Braha et al., 1997).  Additionally, an engineered version of α-HML called H5 
— named because its five amino acids between the 130-134 position were replaced with 
histedines — was used to transport trehalose inside the membrane of mammalian cells (Eroglu 
et al., 2000; Walker et al., 1994).  Intracellular trehalose, in very low concentration, has been 
shown to increase the survival of these cells during cryopreservation.   
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In 2008, the Movileanu laboratory engineered three successful versions of α-HML.  The 
first was made by changing seven amino acids of the trans opening to aspartic acid residues 
(K131D7), the second by making the same mutation at the constriction site of the pore 
(K147D7) and the last one by combining the two mutations together (K131D7/K147D7) 
(Mohammad et al., 2008).  The lab was able to determine that pb2Ba (a designed protein with a 
positively charged sequence, pb2, and a ribonuclease barnase, Ba) interacts with the new α-
HMLs, giving different blockade currents related to the presence of electrostatic blockades.   
An additional alteration involves the building of an aptamer by binding the Cys
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the pore lumen to an oligonucleotide via disulfide bonds (Rotem et al., 2012).  βCD is another 
aptamer that is inserted into the α-HML WT or one of its mutants. It is widely used in detecting 
organic analytes, proteins, DNA and therapeutic agents (Howorka et al., 2001; Movileanu et al., 
2000; Nimjee et al., 2005).  Many pharmaceuticals are not only distinguished but can be 
quantified when bound to βCB, even though stochastic detection of these drugs could also be 
possible using direct mutagenesis of the pore without the help of an aptamer (Gu et al., 1999).  
For example, an antidepressant, such as imipramine, can be distinguished from a first-
generation antihistamine, such as promethazine, by comparing the blockade time histograms 
(Asandei et al., 2011). 
 
1.4.2 Solid state pores 
Alternatively, synthetic nanopores can be made using nanotechnology (Li et al., 2001; 
Storm et al., 2003).  Control over the nanopore size is crucial for the analysis of various 
analytes.  As pointed out from the description of the α-HML structure (see Figure 1.8), the 1.5 
nm constriction acts as a boundary for the translocation of globular proteins and double-
stranded DNA (dsDNA) (Tanaka et al., 2011).  Furthermore, α-HML, as well as all the other 
biological pores, are very sensitive to changes in pH, temperature, buffer and salt 
concentrations as well as background noise.  In the late 90's, constructed metal nanotube 
membranes were capable of transporting selective ions (Nishizawa et al., 1995).  This technique 
didn't meet expectations because of the continuous clogging observed once an analyte was 
inserted.   
In the early 2000s, many groups started fabricating different sized nanopores in silicon 
and silicon nitride membranes (Kim et al., 2006; Li et al., 2001; Storm et al., 2003).  Solid-state 
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pores are manufactured by focussing electron or ion beams onto synthetic membranes using 
techniques like (a) Transmission Electron Microscopy (TEM) or (b) Focused Ion Beams (FIBs) 
(Ayub et al., 2010).  By altering the intensity of the two beams, it is possible to control the size 
of the pore in real time.  These solid-state pores were shown to allow more control over both 
the diameter and the channel length depending on the synthetic membrane chosen.  An 
additional advantage was that solid-state pores are more stable and have the option of 
incorporation into robots and arrays (Dekker, 2007).   
Conversely, these solid-state pores have several disadvantages.  For example, with solid-
state pores crafted in silicon nitride membranes, it is difficult to create a precise pore size 
(Janshoff and Steinem, 2006; Oukhaled et al., 2011).  Additionally, even though it is a precise 
technique, it is very difficult to attain small pores unless the membrane is really thin, in the 50 
nm range (Patterson et al., 2008).  The background noise would also interfere with recording 
the ionic current when the experiment is running, which will lead to uncertainty and difficulties 
in processing and analyzing the data.  
Recently, a new technology was developed that has shown promising results in 
decreasing the electrical noise, as well as enabling more precise control of the pore diameter 
(Eric et al., 2012).  The technique uses controlled break-down electrical cycles (CBD).  
Applying repeated high electric fields to silicon nitride membranes in an aqueous solution 
creates the pore.  The apparatus is an electrically engineered modification of EM.  Other than 
that, it uses the same low-pass filter as would be used in a standard protein nanopore 
experiment.  The formula below describes how to calculate the diameter of the pore when the 
other parameters from previous calculations are already known or are discovered during the 
running of the experiment (Eric et al., 2012; Stefan et al., 2011).   
    
     
   
 
 
 
 
  
   
 
  
       
       
  
  
The thickness of the membrane (leff) and the conductivity of the cylindrical pore in a 
buffer solution (σ) are constant values, which are based on the previous literature and the 
purchased membrane (Stefan et al., 2011).  The conductance (G), measured in Siemens (S), is 
calculated by knowing the voltage applied (V) and the ionic current (I).  This is made possible 
by optimizing the voltage and the intensity of the current.  Finally, these pores not only will 
have different sizes for analyzing many molecules but also are very functional due to their low 
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level of noise.  The CBD technique was successfully replicated in December 2013 in Saskatoon 
with two solid pores at 1.14 nm and 2.70 nm.  No further work has been undertaken on this 
project since that time. 
A new technique for sequencing ssDNA makes use of graphene nanogaps (Schneider et 
al., 2010).  This new solid-state nanopore will lead to the faster detection of the chemical nature 
of the nucleotides (Akca et al., 2011; Postma, 2010).  This technique is still being developed, 
but, it has been shown to be a very promising sequencing tool.  
 
1.4.3 Superimposing an AC field on a standard Nanopore analysis 
In 2012, Radu Stefureac, working in the Lee Lab, discovered that the application of an 
AC voltage on top of the electrophoretic DC voltage improved the discrimination between 
peptides (Stefureac et al., 2012).  It was observed that in a DC field, peptides with small dipole 
moments produce more bumping than peptides with large dipole moments since the former 
don't orient as quickly.  It was shown that it is difficult for the smaller peptides to orient in the 
lumen and translocate through the pore (Stefureac et al., 2006).  It was hypothesized that the 
AC voltage would interact with peptide's dipole moment at the pore vestibule, which would 
prevent molecules with large dipoles from translocating.  In other words, nanopore analysis 
could now be used to discriminate molecules based on their dipole moments (Stefureac et al., 
2012).  An AC voltage with different MHz frequencies was applied using an HP 8662A signal 
generator.  The time scale for events is in the ms range that coincides with KHz frequencies.  
Thus, only frequencies above 10 MHz were attempted.  As well 500 MHz was the upper limit 
of the generator.  Many different combinations of AC frequencies and amplitude were tested.  It 
was found that an amplitude of 200 mV AC voltage imposed over a constant DC voltage 
caused molecules with small dipole moments to enter the pore more easily compared to 
molecules with large dipole moments for frequencies from 10-500 MHz (Stefureac et al., 
2012).  A complete view is shown in Figure 1.9.   
The AC voltage in this thesis was conducted with an HP E4420B (ESG-A Series Analog 
RF Signal Generator) where the upper limit of the generator was 2 GHz.  Higher AC 
frequencies of 1.5 GHz and 2 GHz showed no significant changes in the blockade current 
histograms of the α-helical peptides and so 1 GHz was chosen as the highest frequency. 
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Figure 1.9 Cartoon showing that short peptides with smaller dipole moments rotate slower 
in an AC field (panel 1) and can enter the pore more easily than long peptides with larger 
dipole moments which rotate faster (panel 2). Changes in peptide orientation according to the 
AC frequency (panel 3). Adopted with permission from (Stefureac et al., 2012) Copyright © 
2012 The Royal Society of Chemistry. All rights reserved. 
 
1.5 Peptides and small molecules 
Nanopore analysis has been used for analytical studies for over two decades with multiple 
small molecules such as RNA (Venkatesan and Bashir, 2011), DNA (Schneider and Dekker, 
2012), peptides (Christensen et al., 2011; Stefureac et al., 2006), small proteins (Stefureac et al., 
2008), protein-drug complexes (Tavassoly et al., 2014a); and antibodies (Larkin et al., 2013).  
The use of nanopores for DNA sequencing was first theorized in 1995, and first published in 
1998 (Church et al., 1998).  The hypothesis at that time was that by inserting a ssDNA 
molecule into a bacterial pore, such as α-HML or MspA, the drops in the ionic current would 
depend on the nucleotide passing through. Thus, detailed features of the current trace would 
reveal the sequence of the ssDNA.  
The first successful experiment in detecting ssDNA in the α-HML pore was achieved in 
1996 (Kasianowicz et al., 1996).  It proved that sequencing of nucleic acids is possible in a 
nanopore.  Peptides and proteins have been studied in nanopore analysis as well.  Many 
sequences have been studied showing that peptide properties like size, net charge, structure, 
hydrophobicity, and topology are crucial to understanding the behaviour of peptides in the 
nanopore setup.  The observation of patterns in the current traces and processed results, of the 
different peptides, has led to a better understanding and interpretation of what might happen 
when a peptide interacts with the pore (Christensen et al., 2011; Krasniqi et al., 2012). 
Examples of such peptides include Fmoc-capped α-helical and collagen-like peptides (Stefureac 
21 
 
et al., 2006; Sutherland et al., 2004); β-harpin peptides (Goodrich et al., 2007) and Zn-finger 
peptides (Stefureac and Lee, 2008).  
Additionally, many proteins have been tested in nanopore analysis: histidine-containing 
proteins (Mereuta et al., 2012), myelin basic protein (Baran et al., 2010), maltose-binding 
protein and prion proteins (Krasniqi and Lee, 2012; Madampage et al., 2010).  Nevertheless, 
there are still several other proteins with either no charges in their termini or with a positive net 
charge that cannot be steered electrophoretically into a biological nanopore and are therefore 
difficult to study (Madampage et al., 2010; Stefureac et al., 2008; Stefureac et al., 2010; Zhao et 
al., 2009).  It is still difficult to predict how a small molecule will behave in a nanopore.  It 
might be a simple electrophoretic motion, electroosmotic flow or controlled diffusion.  
Correlating the effect of the voltage on the translocation values, T and I, remains complicated. 
 
1.5.1 Structure and properties of peptides 
The work conducted with the Fmoc-capped α-helical peptides, with general formula 
Fmoc-DxAyKz, and a maximum length of 44.5 Å, dates back almost a decade (Stefureac et al., 
2006).   
 
 
 
Figure 1.10 a. Structure and sequence of the Fmoc-D2A10K2 peptide. b. The dipole moment 
of the α-helical A10. 
 
These peptides have been shown to have very stable secondary structures based on 
Circular Dichroism spectroscopy (CD) (Perutz et al., 2002).  The two negative aspartates (D) 
residues and the two positive lysines (K) residues give these peptides a substantial dipole 
moment that is useful in their analysis within an AC field.  These peptides were originally 
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capped on the N-terminus with Fmoc group, giving them a negative net charge, 
electrophoresing them into the pore vestibule and, thus, increasing the translocation events 
relative to peptides that were not Fmoc-protected (Stefureac et al., 2006).  These properties 
permitted the peptides to orient into the lumen and pass easily through the pore.  Peptides with 
different lengths yield different histograms of blockade current intensities, as well as duration 
times.  Thus, these peptides were useful models to study the effect of an AC field.  
 
1.6 Alpha-Synuclein 
AS is a much longer peptide with a large dipole moment.  There was little known about 
AS before 1997, but during that year, two major discoveries brought a lot of attention to the 
scientific and medical community.  First, a point mutation of Alanine to Threonine at the 53rd 
position, A53T, was found to be related to a familial form of Parkinson's disease 
(Polymeropoulos et al., 1997).  Second, Lewy bodies (LBs), that are fibrils composed of 
aggregates of protein located in PD patients in the Substantia Nigra (SN) of the brain, were 
found to have a strong reaction to antibodies to AS (Spillantini et al., 1997).  These two 
discoveries led to numerous studies, the main focus of which was to understand what effect the 
mutation had and how the accumulation of AS leads to PD.  This led to the finding of the 
SNCA gene, which encodes AS (Singleton et al., 2003).  In addition, a great deal of focus was 
placed on identifying the steps in the molecular pathways leading to the accumulation of AS in 
the brain, as well as possible therapeutic treatments (Breydo et al., 2012). 
 
1.6.1 Structure of Alpha-Synuclein and domains 
AS is an intrinsically disordered peptide of 140 amino acids in length with seven partial 
repeats of 11 amino acids (Goedert, 2001).  The structure and the dynamics of the micelle-
bound human AS protein were obtained in 2005 (Ulmer et al., 2005).  The protein is natively 
unfolded in aqueous solution, but it forms an α-helical structure when bound to a lipid bilayer 
containing phospholipids and finally it forms a β-sheet when aggregation occurs (Stefanis, 
2012).  The protein's name is an arrangement of "Syn" and "nuclein" since the protein is located 
in the presynaptic nerve terminals in the nucleus (Goedert, 2001).  AS is composed of three 
domains: The N-terminus (N-term), the non-amyloid-β-component (NAC) and the C-terminus 
(C-term).  The N-term domain is the membrane-bound domain of the protein, which consists of 
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residues 1-60.  It is an α-helical structure that contains binding domains for apolipoprotein 
complexes.  Additionally, this domain has seven repetitions of the sequence, KTKEGV 
(Clayton and George, 1998; Maroteaux et al., 1988).  The non-amyloidal-β component (NAC) 
consists of residues from 61-95 and is very hydrophobic, playing a major role in the misfolding 
of the protein which later will lead to the formation of fibrils in the brain (Lücking and Brice, 
2000).  The C-term domain, consisting of residues from 96-140, is a very acidic region that is 
very proline-rich, but has no distinct structure (Uéda et al., 1993).  The C-terminus has a net 
charge of -12 whereas the N-term has a net charge of +4 (see Figure 1.11).  Therefore, the 
protein enters the pore through its C-terminus and AS is expected to have a very large dipole 
moment. 
 
 
Figure 1.11 The domains of α-synuclein, including separate and total net charges. Reprinted 
and adapted with permission from (Tavassoly et al., 2014b) Copyright © 2014 FEBS Journal. 
All rights reserved. 
 
AS belongs to the neuronal synuclein family that includes β-synuclein (BS) and γ-
synuclein (GS), but AS is different from the other two due to its NAC region (George, 2002). 
Both BS and GS have been linked to PD, even though there are no traces of these two proteins 
in LBs (Galvin et al., 1999).  BS and GS may be involved in degradation of the hippocampus 
receptors in PD and other neurodegenerative diseases, with symptoms that include loss of short-
term memory, olfaction trouble, and loss of spatial memory and navigation.  Surprisingly, the 
WT version of BS was shown to be neuroprotective, preventing AS aggregation which leads to 
neuronal death.  On the other hand, point mutations in BS such as V70M or P123H were shown 
to be related to Dementia with Lewy Bodies (DLBs).  The mutations of BS in the 70th and 
123rd position are dominant traits.  Using techniques such as histopathology and 
immunohistochemistry, it was shown that BS is in brain sections of the DLBs patients (Ohtake 
et al., 2004; Park and Lansbury, 2003).  Overexpression of Synoretin, a member of the GS 
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subfamily, was found in the retina of Alzheimer's disease (AD) patients (Surguchov et al., 
2001).  AS is found largely in the brain, but also in small amounts in such organs as the heart, 
the kidney, the lungs, muscle tissue, as well as others (Baltic et al., 2004).  Interest is focussed 
on the presence of AS in the brain as related to its main function and relationship with PD.  AS 
is initially observed during neuronal development in the fetus.  Subsequently, AS is implicated 
in the neuron structure, especially in the synapse region, and was shown to be involved in 
neuronal transmission (Murphy et al., 2000).  Proof of its involvement in synaptic transmission 
was revealed in 2005 when it was shown that AS regulates cysteine string protein-α (CSP-α), a 
presynaptic protein linked to loss of neuronal function (Chandra et al., 2005).  For the above-
mentioned reasons, one of the functions of AS seems to be related to controlling assembly of 
the soluble N-ethylmaleimide-sensitive factor attachment receptors (SNARE) complex 
(Chandra et al., 2005).  This research was based on a mouse model.  The Chandra group noticed 
that knocking out the protein CSP-α in mice caused neurodegeneration.  Mice born with a CSP-
α-deficiency showed failings in synaptic transmission within 2 to 3 weeks of age, and after they 
were 1 to 4 months the CSP-α-deficiency proved lethal.  Additionally, the deletion of CSP-α 
was shown to cause loss of the proper assembly of the SNARE complex.  For example, levels 
of plasma membrane SNARE proteins like SNAP-25, SNAP-32, synaptobrevin were decreased 
in the CSP-α knockout mice (20-40%).  All these proteins are involved in the release and 
regulation of neurotransmitters.  These CSP-α knockout mice were then treated with transgenic 
WT AS where, surprisingly, it was shown that the SNARE complex assembly was corrected.  
Independent assays on sodium dodecyl sulfate (SDS) gels showed that the SNARE complex 
assembly was indeed abnormal in the mice with CSP-α knockout and regular after the 
expression of WT AS.   
Thus, it appears that the function of AS is related to synaptic transmission and modulator 
of neurotransmitter release.  Nevertheless, the physiological role of α-synuclein still remains 
unknown. 
 
1.6.2 Clinical significance of alpha-synuclein in Parkinson's disease 
Diseases due to protein misfolding have become a widespread focus for many groups.  
The term "Protein misfolding diseases" refers to the neuropathology of the abnormal deposit of 
proteins not only in PD patients, but in patients with other neurodegenerative diseases such as 
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Multiple-System Atrophy (MSA), AD, Amyotrophic Lateral Sclerosis (ALS), DLBs and 
Neurodegeneration with Brain Iron Accumulations type 1 (NBIA) (Kahle, 2008; Stefanis, 2012; 
Zilkova et al., 2006).  The usage of this new terminology started back in 1997 when it was 
discovered that the SNCA gene plays a big part in sporadic familial PD (Baba et al., 1998).  
The discovery of point mutations in the SNCA gene has led to the detection of other familial 
forms of PD.  Additionally, both duplication and triplication of the locus containing the SNCA 
gene or mutations of the 4q21-23 human chromosome, have been related to rare familial PD 
(Forman et al., 2005; Savitt et al., 2006). PD is clinically diagnosed by L-dopa-responsive 
motor impairments including slowness of movement, muscular rigidity and tremors (Forman et 
al., 2005; Giasson et al., 2004; Jankovic, 2008; Stefanis, 2012).  PD is the second most common 
neurodegenerative disease after AD.  There are multiple isolated genetic factors that cause 
degeneration of the nervous system and lead to PD (Farrer, 2006; Feany, 2004; Giasson et al., 
2004).  However, these point mutations are extremely uncommon forms of familial PD.  More 
than 90% of sporadic PD is characterized by the accumulation of AS in LBs (Forman et al., 
2005; Stefanis, 2012).  Accumulation of AS occurs when the natively unfolded protein begins 
to aggregate into β-sheet like structures that may form inclusion bodies called LBs.  
The genetic factors of PD were the first to be discovered. In 1990, it was observed that 
many members of a family in Contursi Terme, a village in Southern Italy, had PD.  Responsible 
for the increased number of cases of this disease was a defect in the 4q21-23 chromosome, 
which is the chromosome to which AS maps.  The first mutation observed of the SNCA gene 
was the replacement of guanine with adenine at 209 position, leading to an A53T point 
mutation (Polymeropoulos et al., 1997).  As expected, this new revelation led to a more 
profound study of the SNCA gene.  Thus, it was possible to detect more point mutations of 
familial PD: (a) A30P, where guanine at position 88 is substituted with cytosine in the SNCA 
gene, leading to a replacement of alanine at the 30th site of AS with proline (Krüger et al., 
1998); (b) E46K, the other mutation of AS where a negatively charged glutamate is mutated to 
a positively charged lysine.  This AS mutant is known to cause a much higher level of 
misfolding leading to a higher amount of aggregation than the other two mutations, A53T and 
A30P (Zarranz et al., 2004); (c) H50Q, a mutation within exon 4 of SNCA, which leads to a 
replacement of histidine with glutamine (Appel-Cresswell et al., 2013); and (d) G51D, leading 
to the discovery of a new parkinsonian-pyramidal syndrome, from a French family.  This new 
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PD phenotype was shown to have a generally faster progression of the disease with the death of 
the patient within a few years (Lesage et al., 2013).  Additionally, the SNCA gene is also 
related to autosomal-dominant familial PD through duplication and triplication (Singleton et al., 
2003).  For example, carriers of the triplication of the gene are predicted to have three fully 
functional copies of SNCA.  It is possible that the increased dosage of this gene is the cause of 
PD in this case, although, it is very important to mention that the SNCA gene is also linked to 
sporadic cases of PD through genome-wide association studies (GWAS) (Klein and Ziegler, 
2011; Nalls M. A. et al., 2011). 
Figure 1.12 summarizes the causes that enhance the aggregation of AS, which later leads 
to neuronal death in PD.  
 
 
 
Figure 1.12 Nerve cell death model of PD. Reprinted with the permission from (Goedert, 
2001) Copyright © 2001 Macmillian Magazines Ltd . All rights reserved. 
 
In 2015, the Prusiner lab identified a strain of AS that causes MSA that could possibly be 
a prion (Prusiner et al., 2015).  Prions are proteins that are capable of misfolding in different 
ways and are known to cause Transmissible Spongiform Encephalopathy (TSE), a condition in 
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where cerebral cortex deterioration leads to holes that make that part of the brain look like a 
sponge (Kupfer et al., 2009; Prusiner, 1998).  It is possible to compare them to viruses because, 
at least, one of these misfolded conformations is transmissible to other animals, similar to a 
viral infection. The Prusiner lab studied brains of MSA and PD deceased patients.  The group 
homogenized these brains to test for transmission in genetically engineered cells expressing AS 
and the A53T AS mutation and in transgenic mice expressing A53T.  The MSA samples were 
transmitted to the cells and transgenic mice, while there was no transmission for the PD 
samples.  This led to the assumption that the AS strain that causes MSA could be a prion 
because it was transmissible and caused severe neurodegeneration (Prusiner et al., 2015).  
 
1.6.2.1 Misfolding that leads to aggregation 
As mentioned, PD pathology is triggered by the aggregation of AS.  AS is a stable 
intrinsically disordered protein; nevertheless, under certain conditions, it can aggregate and 
form inclusion bodies. Classical LBs, are eosinophilic inclusions that are approximately 10 nm 
wide found in dopaminergic neurons (McKeith et al., 1996).  The deposition of AS into LBs is 
a progressive result of aggregation that takes place within neurons of the SN of the brain.  
The aggregation of AS is shown to the right of Figure 1.13.  The aggregation starts when 
the native unfolded AS misfolds into spherical- ring- or string-like structures.  These structures 
represent an intermediate stage where the protein is partially folded.  This type of misfolding is 
generated by point mutations of AS as well as environmental factors.  These partially folded 
structures start the oligomerization of the protein due to their hydrophobic surfaces.  These 
new-formed oligomers are β-sheets-like structures and can be observed in vitro via EM, but 
very difficult to detect in vivo.  It is possible to trap a few of the oligomeric forms on native gels 
or study by size-exclusion chromatography (Emmanouilidou et al., 2010). Further enhancement 
of this oligomerization will lead to fibrillization and eventually will form fibrils that will 
accumulate to LBs.  As shown in the left side of Figure 1.13 there are several factors that might 
enhance the aggregation of AS into protofibrils, such as the familial mutations A53T, A30P, 
and E47K.  Surprisingly, only A30P and A53T form more protofibrils than the WT version of 
AS, whereas the E47K mutation forms fewer protofibrils than the WT.  Furthermore, A53T 
forms more fibrils than the WT version, as well as all the other mutations (Conway et al., 
2000).  There are further examples on the left side of Figure 1.13 of different modifiers. 
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Stimulation of the polo-like kinase 2 (PLK2) by electrical changes in the neurons enhances 
aggregation.  PLK2 is responsible for the phosphorylation of AS at Ser129, thus forming more 
oligomers and fibrils.  Additionally, calpain protease truncations and nitration, through nitric 
oxide (NO) all modify AS and increase its aggregation potential (Cookson, 2009).  
 
 
Figure 1.13 The chain reaction of the AS aggregation and its toxicity. Reprinted and adapted 
with the permission from (Cookson, 2009) Copyright © 2009 Cookson; licensee BioMed 
Central Ltd. All rights reserved. 
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1.6.2.2 Role of other factors in Parkinson's disease 
 The PARK family, including PARK 1, 3, 4, 6 and 11, represent a series of genes that, if 
mutated, are responsible for the pathogenesis of familial PD (Bekris et al., 2010; Farrer et al., 
1999; Gasser et al., 1998; Valente et al., 2001).  An additional protein related to PD is parkin, 
which is encoded by the PARK2 gene.  Mutations of the PARK2 gene are known to cause a 
familial form of PD, which is known as autosomal-recessive juvenile parkinsonism (AR-JP) 
(Kitada et al., 1998).  The physiological function of this protein is unknown, much like the 
function of AS, but it is hypothesized that parkin helps in degrading other proteins that are toxic 
to the neurons responsible for dopamine production and transportation.  However, it is still not 
clear how the loss of parkin function leads to death of these neurons.  It has been shown that a 
protein called synphilin-1 links parkin and LBs in PD (Engelender et al., 1999).  It was shown 
that the protein-protein complex between AS and synphilin-1 is overexpressed and is the cause 
for the rapid formation of these inclusion bodies (Moore et al., 2005).  In addition to PARK2, 10 
more genes were found to be related to forms of PD.  These genes are divided into two groups: 
(a) autosomal dominant (AD) and (b) autosomal recessive (AR).  As for the parkin mutations 
such as PARK2 or PARK6, which are known to cause PD, they have no relation to fibril 
pathology (Kitada et al., 1998; Valente et al., 2001).   
Environmental factors have also been studied as external causes of PD (Di Monte et al., 
2002).  Many reports of PD cases from factors such as heavy metals have been published.  For 
instance, iron and manganese accumulation in the SN part of the brain could possibly induce 
dopamine to auto-oxidize and produce free radicals, which play a significant role in PD 
pathogenesis (Montgomery, 1995). Another factor is 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (MPTP), a secondary compound created unintentionally during the 
production of 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP), which is an opioid analgesic 
drug (Exner et al., 2012).  MPTP as itself is not toxic, but once it crosses the blood-brain barrier 
it metabolizes into 1-methyl-4-phenylpyridinium (MPP
+
).  It is the MPP
+
 cation that induces 
death of the dopaminergic neurons of the pars compacta in the SN region.  Pesticides, such as 
rotenone and paraquat, are also factors and induce oxidative stress and degeneration of 
dopaminergic neurons (Berry et al., 2010; Franco et al., 2010).  Additionally, synthetic organic 
compounds like 6-hydroxydopamine (6-OHDA) which is known as oxidopamine, is used to 
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selectively destroy dopaminergic neurons (Breese et al., 2005).  Finally, head-related injuries 
may also trigger PD (Liu et al., 2003). 
 
1.7 Protein-Drug complexes 
The use of nanopore technology to discover drugs that bind to AS, is being researched as 
a possible way to treat Parkinson's disease (Kakish et al., 2015b; Tavassoly et al., 2014a).  
 
1.7.1 Drugs that interact with Alpha-Synuclein 
Drugs that are known to bind to AS and change the conformation, would be optimal 
candidates for studies in an AC field.  Several drugs that are known to have neuroprotective or 
neurotoxic effects were tested using both nanopore analysis and ITC (Kakish et al., 2015a; 
Kakish et al., 2015b; Tavassoly et al., 2014a).  These studies were conducted to obtain a better 
understanding of the drug-AS conformational changes and possible binding sites.  Several 
drugs have shown to help relieve the symptoms of PD, including rasagiline, which is an 
inhibitor of MAO-B and is widely used by PD patients (Gallagher and Schrag, 2008; Kakish et 
al., 2015b).  It prevents the breakdown of dopamine in neuronal mitochondria, which increases 
its chance for re-absorption and later use by the synapse.  In contrast, numerous recreational 
drugs such as heroin and methamphetamine have been shown to induce PD symptoms by 
interfering with dopamine metabolism in neurons.  Initially, caffeine and nicotine were taken 
into consideration after epidemiological studies showed that the intake of coffee and the 
smoking of tobacco in high doses had a direct association with PD (Quik, 2004; Ross et al., 
2000).  These drugs have been shown to help prevent PD; suggesting a neuroprotective role 
(Ascherio et al., 2001; Kelton et al., 2000; Villafane et al., 2007).  It is assumed that these drugs 
bind to AS, forming a loop conformation, as shown in Figure 1.14 b; therefore, they prevent the 
NAC region of these proteins from aggregating (Tavassoly et al., 2014a).  Later, other drugs, 
such as S-1-aminoindan, 3-methoxytyramine, and metformin, have been shown to have 
neuroprotective abilities as well (El-Mir et al., 2008; Huang et al., 1999; Patil et al., 2014; 
Scatton et al., 1983).  Alternatively, drugs like amphetamine and cocaine were shown to 
increase the risk of PD (Graybiel et al., 1990; Myers and Earnest, 1984).  They are assumed to 
form a compact complex with AS leaving the NAC region free, thus promoting aggregation 
(Kakish et al., 2015a).   
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Figure 1. 14 Two possible conformation of the drug-AS complexes. a. The drug binding site 
is in the N-terminus which makes the protein to intake a half a bow configuration and b. The 
drug binding cite is in both the N- and C-terminus forming a loop conformation.  
 
As previously observed, the blockade current histogram of AS alone is mostly composed 
of translocation events with intensity at -86 pA (Madampage et al., 2012).  Each drug that binds 
to the protein causes a current shift with respect to the translocation events and/or an increase in 
the bumping event proportions.  For nicotine, only the (-)-nicotine isomer has been shown to 
bind to both the N-and C- termini forming a loop conformation (Figure 1.14 b), whereas the 
(+)-nicotine isomer binds to the N-terminus forming a half bow conformation (Figure 1.14 a)  
(Tavassoly et al., 2014a).  Published results have shown that (-)-nicotine causes a major shift in 
the translocation events from -86 pA to -65 pA (Tavassoly et al., 2014a).  Based on the 
conformations the drug-protein complex adopts once the drug binds to AS it was assumed that 
(-)-nicotine has a neuroprotective effect (Kakish et al., 2015a). Additionally, 3-
methoxytyramine is a metabolite of the previously studied 3-methoxydopamine, which is 
derived from dopamine, but is more stable and less susceptible to oxidation (Karoum et al., 
1994; Wood and Altar, 1988).  Dopamine binds to AS and forms a loop conformation because 
it binds to the N-terminus as well as the C-terminus (Tavassoly et al., 2014b).  Dopamine-like 
drugs were proven to behave like dopamine and, as such, can stimulate the nerve cells.  For 
example, L-3,4-dihydroxyphenylalanine (L-DOPA), which is metabolized to dopamine, has 
been shown to be a good therapy for PD patients as their motor symptoms were significantly 
ameliorated, although, it also causes various side effects (Cools, 2006; Cotzias  et al., 1969).  
32 
 
The blockade histogram of 3-methoxytyramine is the same as 3-methoxydopamine and has a 
single peak that is shifted to -40 pA.  This suggests the same change in structure of AS that is 
been observed previously in the case of 3-methoxydopamine  (Tavassoly et al., 2014a).  Thus, it 
is assumed that this drug could be neuroprotective as well.   
Metformin is another drug tested with nanopores that is given to patients with diabetes, 
especially type 2 diabetes (Dunn and Peters, 1995; Group, 2002).  Metformin has a unique 
structure compared to the other six drugs since it has no aromatic ring and is a small dication.  
It was publicized in 2014 that metformin helped PD-induced mice, with chronic MPTP 
administrations, by acting as a neuroprotective drug (Patil et al., 2014).  Its blockade histogram 
revealed a major peak that is shifted to -65 pA.  Therefore, this drug is presumed to be 
neuroprotective as well.  Finally, S-1-Aminoindan may also be neuroprotective.  It has a major 
translocation peak at -73 pA, which reveals that the drug binds tightly to the protein and helps 
AS from misfolding (Kakish et al., 2015b). 
The second group of drugs studied in this thesis includes those that interfere with the 
transport of dopamine in neuron synapses, such as amphetamine.  Amphetamine binds to AS 
causing a large bumping peak and a smaller translocation peak at the same position as AS (-86 
pA).  Abusers of amphetamine have been shown to have an increased risk of having PD later in 
their lives, an observation similarly seen in methamphetamine abusers (Curtin et al., 2015).  
Lastly, cocaine is also known to be a drug that interferes with dopamine transportation or its 
metabolism in neurons (Gawin and Ellinwood, 1988).  Some cases of long-term cocaine abuse 
have been shown to increase the risk of PD and some other Parkinson-like symptoms (Lloyd et 
al., 2006).  There is an ongoing debate on the relationship between cocaine and PD (Dhopesh et 
al., 1997).  
 
1.8 Hypothesis 
The main hypothesis of this thesis is that superimposing an AC voltage in nanopore 
analysis is useful for various applications.  Application of an AC voltage can be used to 
discriminate between α-helical peptides based on differences in their dipole moments.  
Additionally, the application of an AC field can be employed to investigate the conformational 
changes of AS-drug complexes. 
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1.9 Objectives 
a. To study the discriminatory effects of different combinations of AC frequencies 
and DC amplitudes for α-helical peptides and ssDNA fragments.   
Initially, a simple series of peptides will be analysed consisting of the previously studied 
α-helical peptides of different lengths.  These include Fmoc-D2A10K2, Fmoc-D2A14K2 and 
Fmoc-D2A18K2 (Stefureac et al., 2006).  Also a retro-inverse sequence of Fmoc-D2A10K2 will 
be analyzed (Fmoc-K2A10D2).  Our goal is to show that the translocation of these peptides can 
be altered, or even prevented, by applying the right combination of AC frequency and DC 
voltage.  Lastly, two ssDNA will be analyzed, oligo-dT20 and d18, to show how ssDNA would 
interact in an AC field.  In all studies, the DC voltage will be fixed at levels of 60 mV, 100 mV 
and 140 mV.  Superimposed on this will be a 200 mV AC voltage with frequencies between 10 
MHz and 1 GHz.  
 
b. To investigate the effect of an AC fields on the behaviour of AS and its fragments.   
These studies will be extended to larger proteins such as AS (Tavassoly and Lee, 2012).  
Different AS conformations may be readily distinguished in an AC field because of differences 
in their dipole moments.  Peptide fragments of AS, such as N-terminus, C-terminus and ΔNAC 
will also be studied.  Our goal is to show that longer proteins with a large dipole moment can be 
prevented from translocating through the α-HML pore in the presence of an AC field. 
 
c. To observe and elucidate the effect of the AC field on AS-drug complexes. 
Our goal is to show that with the help of an AC field we are able to distinguish the 
different AS conformations induced by seven drugs (S-1-aminoindane, 3-methoxytyramine, 
metformin, caffeine, (-)-nicotine, cocaine and (+)-amphetamine), as they bind to different sites 
of the protein (Kakish et al., 2015b; Tavassoly and Lee, 2012).   
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2. MATERIALS AND METHODS 
 
2.1  Reagents, Equipment and Software  
Table 2.1 and 2.2 describes the chemical and biological reagents, equipment and software 
that were used in this thesis, including the information of their suppliers.  
 
 
Table 2.1 a. List of chemical and biological compounds with their respective suppliers. 
 
Reagents and Equipment Supplier 
 
a. Chemical and Biological Compounds: 
 
1,2-diphytanoyl-sn-glycero-3-phosphocholine in chloroform 
3-Methoxytyramine hydrochloride 
4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES) 
(-)-1-Aminoindan 
(+)-Amphetamine 
Alpha-Hemolysin 
Alpha-Synuclein 
Alpha-Synuclein, N-term (1-60) 
Alpha-Synuclein, C-term (96-140) 
Alpha-Synuclein ΔNAC 
Caffeine 
Cocaine hydrochloride (solution) 
Decane (anhydrous) 
Disodium Ethylenediaminetetraacetic dehydrate (EDTA-NA2) 
DNA strands 
Fmoc-D2A10K2 (A10) 
Fmoc-D2A14K2 (A14) 
Fmoc-D2A18K2 (A18) 
Metformin (hydrochloride) 
Methanol (%) 
(-)-Nicotine, analytical standard 
Nitrogen (compressed gas) 
Nuclease-free water 
Potassium chloride (KCl) 
Potassium phosphate dibasic (K2HPO4) 
Potassium phosphate monobasic (KH2PO4) 
RI-Fomc-K2A10D2 
Sodium hydroxide, pellets (NaOH) 
Avanti Polar Lipids 
Sigma-Aldrich 
BDH 
Sigma-Aldrich 
Sigma-Aldrich 
Sigma-Aldrich 
rPeptide 
rPeptide 
rPeptide 
rPeptide 
Sigma-Aldrich 
Sigma-Aldrich 
Sigma-Aldrich 
Sigma-Aldrich 
Regional DNA synthesis lab 
CHI Scientific 
CHI Scientific 
CHI Scientific 
Sigma-Aldrich 
Thermo Fisher Scientific 
Sigma-Aldrich 
Praxair 
Life Technologies 
EMD 
Thermo Fisher Scientific 
Thermo Fisher Scientific 
CHI Scientific 
EMD 
 
35 
 
 
 
 
Table 2.1 b. List of supplies, equipment and software with their respective suppliers. 
 
Reagents and Equipment Supplier 
 
b. Equipment, software and supplies: 
 
BC-535 amplifier 
Borosilicate glass capillaries (round) 
Digitizer, DigiData 1440A 
Falcon tubes 
Faraday Cage 
Filters (0.2 μm) 
Glass beakers, vials and caps 
Headstage model BC-535 
HP E4420B Signal generator 
LPF-8 eight-pole low pass Bessel filter 
Microcentrifuge, Hettich Mikro 20 
Microliter syringes 
Microcentrifuge tubes, non-stick 
NanoAnalyze (software) 
Nitrile gloves 
ONEAC PC750A power supply 
Origin 7 (graphing software) 
Paintbrush size 000 
Parafilm 
pClamp 10.4 (analyzing software) 
Perfusion bilayer chamber and cup 
pH meter 
Pipettes 
Pipette tips (10, 200, 1000 and 5000 μl ) 
Silver paste 
Silver wire 
Syringe needles 
Syringes (μl) 
Syringes (ml) 
Tektronix TDS220 digital oscilloscope 
Warner Instruments 
Produstrial 
Axon Instruments 
VWR 
Warner Instruments 
Sarstedt 
Kimble Chase & VWR 
Warner Instruments 
TRS RenTelco/Agilent 
Warner Instruments 
Hettich Zentrifugen 
Hamilton 
Thermo Fisher Scientific 
TA Instruments 
Kimberly-Clark 
ONEAC 
OriginLab 
Island Blue 
VWR 
Axon Instruments 
Warner Instruments 
Thermo Fisher Scientific 
Eppendorf 
Thermo Fisher Scientific 
Alfa Aesar 
Alfa Aesar 
Becton Dickinson 
Hamilton 
Becton Dickinson 
Tektronix 
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Table 2.2 List of companies and their addresses. 
 
Supplier Address 
Alfa Aesar 
Avanti Polar Lipids 
Axon Instruments 
BDH 
Becton Dickinson 
CHI Scientific 
EMD 
Eppendorf 
Hamilton 
Hettich Zentrifugen 
Island Blue 
Kimberly-Clark 
Kimble Chase 
Life Technologies 
ONEAC 
OriginLab 
Praxair 
Produstrial 
Regional DNA synthesis lab 
rPeptide 
Sarstedt 
Sigma-Aldrich 
TA Instruments 
Tektronix 
Thermo Fisher Scientific 
TRS RenTelco 
VWR 
Warner Instruments 
Alfa Aesar, Ward Hill, MA, USA 
Avanti Polar Lipids, Alabaster, AL, USA 
Molecular Devices, Sunnyvale, CA, USA 
VWR International, Edmonton, AB, Canada 
Becton Dickinson Canada, Mississauga, ON, Canada 
CHI Scientific, Maynard, MA, USA 
EMD Millipore, Gibbstown, NJ, USA 
Eppendorf Canada, Mississauga, Ontario, Canada 
Hamilton Company, Reno, NV, USA 
Andreas Hettich GmbH & Co.KG, Tuttlingen, Germany 
Island Blue Print, Victoria, BC, Canada 
Kimberly-Clark Inc., Mississauga, Ontario, Canada 
Kimble Chase, Vineland, NJ, USA 
Life Technologies, Burlington, ON, Canada 
ONEAC, Libertyville, IL, USA. 
OriginLab, Northampton, MA, USA 
Praxair, Saskatoon, SK, Canada 
Produstrial, LLC; Larkspur Lane, Fredon, NJ, USA 
University of Calgary, Calgary, AB, Canada 
rPeptide, Bogart, GA, USA 
Sarstedt, Montreal, QC, Canada 
Sigma-Aldrich Canada Ltd., Oakville, ON, Canada 
New Castle, PA, USA 
Tektronix, Beaverton, OR, USA 
Fisher Scientific Company, Ottawa, ON, Canada 
TRS-RenTelco, Dollard-des-Ormeaux, QC, Canada 
VWR International, Edmonton, AB, Canada 
Warner Instruments, Hamden, CT, USA 
 
2.2  Nanopore Technology 
2.2.1 Nanopore analysis apparatus  
All the nanopore experiments conducted in this thesis used a patch-clamp setup.  As seen 
in Figure 2.1, the system is composed of several components: (a) the perfusion cups, (b) the 
silver/silver chloride electrodes, (c) the head-stage.  The components were located inside (d) a 
Faraday cage. The head-stage was connected simultaneously to (e) the patch-clamp amplifier 
and (f) the signal generator, the latter is connected beforehand to (g) an oscilloscope to adjust 
the AC voltage.  The ionic signal makes its way to (h) the digitizer and finally can be monitored 
(i) as a screen shot on a computer via the Clampex© software. 
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Figure 2.1 Images of the patch-clamp setup: a. perfusion cups composed by the perfusion 
cup and the holder, b. Ag/AgCl electrodes, c. head-stage, which are located in d. the Faraday 
cage. The head-stage is connected to: e. patch-clamp amplifier, f. signal generator, g. 
oscilloscope, h. digitizer and lastly i. screen shot.  
 
The perfusion unit is composed of two cups (Figure 2.1 a): (a) the Teflon perfusion cup 
(white) has a small aperture of 150 μm, where the bilayer membrane will be painted and (b) the 
Delrin cup holder (black), which has a nylon screw to tighten the perfusion cup to prevent 
38 
 
leakage between the two chambers.  Both compartments have the same volume capacity of 1 
ml.  The two compartments, cis (black) and trans (white) are separated by the perfusion bilayer.  
These cups are easily maintained and have a long life.  The perfusion unit was then placed on a 
nitrogen floating table (Kinetic Systems), which will reduce any external vibrations or signals, 
in the bounds of a Faraday cage (Warner Instruments) to protect the nanopore experiment from 
external electrical and static noises.  An Ag/AgCl electrode was then placed in each 
compartment; the cathode placed in the cis side and the anode placed in the trans side.  Before 
the start of an experiment, the electrodes were cleaned off prior oxidation layers with sand 
paper and placed in bleach for 2 to 3 hours.  The two electrodes are directly connected to the 
head-stage (BC 535, Warner Instruments).  The signal is later transmitted to the 10 kHz low-
pass filtered with an eight-pole Bessel filter patch-clamp (Warner Instruments), where DC 
voltages of 60, 100 and 140 mV were applied.  Simultaneously the signal is transmitted to the 
HP E4420B signal generator (ESG-A Series Analog RF Signal Generator, 2 GHz, Hewlett 
Packard), where an AC voltage of 200 mV with frequencies between 10 MHz-1 GHz was 
applied.  The AC amplitude and frequencies were initially regulated by Tektronix TDS 220 (2 
Channel, digital real time Oscilloscope 100 MHz, 1 GHz/s) then added to the head-stage.  The 
patch-clamp and signal generator voltage is combined by a joined cable and is applied directly 
to the head-stage.  Lastly, the signals were digitized at 100 kHz by Digidata 1440 (Axon 
Instrument) and then recorded by a Personal Computer (PC) running PClamp 10.1 (Axon 
Instrument).  All the equipment involved the nanopore analysis apparatus was powered by a 
power bar (ONEAC) to reduce noise coming from the main supply. 
 
2.2.2 Formation of the lipid bilayer and insertion of the pore 
Prior to each bilayer painting, the CHCl3-lipid solution was dried under a vacuum for 3 to 
4 hours and then re-dissolved in 25 μl of decane to a 30 mg/ml final concentration (Stefureac et 
al., 2006).  Initially, this lipid bilayer was made by twice painting 1,2-diphytanoyl-sn-glycero-
3-phosphocholine from Avanti Polar Lipids (Alabaster, Alabama) with a size 000 brush onto 
the 150 μm aperture of the Teflon wall in the perfusion cup (white).  The lipid bilayer was then 
dried under a 10 pound per square inch (10 psi) flow of compressed nitrogen gas. The perfusion 
cup was then inserted in the holder (black) and tightened.  After the cups are secured in the 
Faraday cage, they are filled with 1 ml electrolyte solution.  The electrolyte solution used for 
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the Fmoc peptides and the DNA strands was 1 M KCl with 10 mM potassium phosphate (9.87 
ml of 100 mM of dipotassium phosphate + 0.13 ml of 100 mM monopotassium phosphate) 
buffer pH 7.8 (Christensen et al., 2011).  While, the buffer used for the AS, its domains, and 
AS-drug complexes studies contained 1 M KCl in 10 mM HEPES at a pH 7.8, with the addition 
of 1 μM of EDTA only on the cis side to chelate dicovalent metal such as Cu2+, Zn2+ or Mg2+  
that might be present in the solution (Krasniqi and Lee, 2012).   
 
 
 
Figure 2.2 a. Capacitance at 72 pF. b. An optimal inserted pore (100 pA) at a DC potential 
of 100 mV. c. Bumping, intercalation and translocation events observed after 1μM AS was 
inserted. 
 
A voltage of 100 mV was applied from the patch-clamp to make sure a stable bilayer 
membrane was formed.  Afterward, the brush was used to thin the multilayer coating in the cis 
side until a stable membrane was formed. Additionally, to help control the stability of the 
membrane, a 5 ml syringe was inserted in the cis compartment through a hole located on the 
right side of the cup holder.  After a stable membrane was formed and the capacitance is in the  
range of 70 pF range, the pore solution was added (Figure 2.2 a).  The stock solution of α-
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HML, from Sigma Aldrich Canada, Ltd. (Oakville, Ontario), at 0.5 mg per vial, was diluted 
with 2 ml of 1 M KCl in 10 mM potassium phosphate buffer, to achieve a concentration of 0.25 
mg/ml.  The amount inserted in the cis compartment is between 5 to 15 μl, bringing the final 
concentration between 1.25 μg/ml to 3.75 μg/ml.  For an optimal inserted pore at a DC potential 
of 100 mV, the open pore current should be 100 pA or a multiple (Figure 2.2 b).  Once a stable 
pore is obtained, the analyte can be added and tested (Figure 2.2 c). 
The first analytes to be tested were the α-helical peptides.  These peptides were custom 
designed by CHI Scientific (Maynard, MA, USA) and a Fmoc- group capped to the N-terminus 
(98% pure).  The peptides were dissolved in 1 M KCl with 10 mM potassium phosphate at 2 
mg/ml concentration and once a stable pore is inserted, 10 μl of the stock solution was added to 
the cis compartment bringing the final concentration to 0.002 mg/ml. Spartan software 
calculated the length of these peptides whereas the molecular weight was calculated by 
GenScript online software.  Both the length and the molecular weight were later confirmed by 
CHI Scientific (Maynard), the company that manufactured these peptides.  The dipole moment 
was calculated manually (Creighton, 1993).  ssDNA was tested, at a final confirmation of 1 
μM.  The ssDNA were synthesized by the regional DNA synthesis lab (University of Calgary).  
Additionally, AS and its three domains, N-terminus, C-terminus and the ΔNAC were purchased 
from rPeptide (Bogart, GA, USA) all having protein purity >95%.  The peptides were dissolved 
in 1 ml of nuclease-free water to a final concentration of 1 mg/ml for α-synuclein and 0.5 
mg/ml for its three domains.  For each peptide the final concentration in the cis compartment 
was 1 μM.  Finally, the seven drugs were acquired from Sigma-Aldrich (Oakville, Ontario, 
Canada) with purity >98%.  The drugs were dissolved in methanol at a concentration of 2 mM. 
5 μl of the stock solution was added to the cis chamber to give a final drug concentration of 10 
μM. 
 
2.2.3 Data collecting, processing and graphing 
Any large molecule such as a peptide, ssDNA, protein or protein-drug, which interacts 
with the pore, will cause a drop in the blockade current (I) for a blockade time (T), which is 
measured with the patch clamp apparatus (Figure 2.3) (Lamichhane et al., 2013).  An AC 
amplitude of 200 mV and five frequencies: 10, 50, 100, 500 MHz and 1 GHz were investigated 
with an HP E4420B signal generator (ESG-A Series Analog RF Signal Generator, 2 GHz, 
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Hewlett Packard).  The signal produced during the interaction of an analyte with the pore was 
received by the patch-clamp and filtered by the LPF-8 eight-pole Bessel filter (Warner 
Instruments).  Lastly, the signal was forwarded to the digitizer (Axon Instrument) where the 
analog signal is converted to digital.  The signal is then recorded in real time via the Clampex 
software, PClamp 10.1 (Axon Instrument) which is visually displayed to a PC.  The PClamp 
10.1 used a fixed-length mode to recorded the events as seen from the screen shot in Figure 2.2 
c.  The files recorded have no more than 500-600 events.  These files were later processed using 
the Clampfit software where the background noise was removed and events were divided into 
three groups: translocation, intercalation, and bumping.  Finally, the events were graphed using 
the Origin software (OriginLab) where the blockade current population of each event was fitted 
using a Gaussian function.  From these graphs it was possible to obtain the blockade current 
and the proportion of events at each current.  Additionally, with the help of the same Origin 
software, it was possible to calculate the characteristic blockade time of each population using 
an exponential function (ExpDecay1).   
 
Figure 2.3 a. The patch-clamp setup at a 100 mV DC allows the ions to flow in the pore and 
create an ionic current, b. The interruption of the current when an analyte interacts with the 
pore and c. the disruption of the blockade current and time caused by the analyte.  
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3. RESULTS 
 
3.1  Nanopore analysis of four alpha-helical Peptides  
Earlier nanopore work at a 100 mV DC voltage, was conducted with α-helical peptides of 
the general formula fluorenylmethoxycarbonyl (Fmoc)-DxAyKz (Amblard et al., 2006; 
Stefureac et al., 2006).  These are listed in Table 3.1 along with several common properties.  As 
seen in Table 3.1, these sequences have the same net charge, but different lengths and dipole 
moments.  RI-A10 is composed of D-amino acids and has a larger negatively charged C-
terminus, giving a larger dipole moment than A10. 
 
Table 3.1 The sequence of the peptides, their molecular weights, their net charges, their 
lengths and their dipole moments (calculated from modeling simulations using Spartan 
software). 
 
Peptide 
Molecular 
weight 
(g/ml) 
Net 
charge 
(at pH 7) 
Length 
(Ȧ) 
Dipole 
Moment 
(Debye) 
Fmoc-D2A10K2  
Abbrev: A10 
1436.59 -1 28.2 260 
Fmoc-D2A14K2 
Abbrev:A14 
1720.9 -1 33.7 329 
Fmoc-D2A18K2 
Abbrev:A18 
2005.22 -1 39.1 400 
RI-Fmoc-K2A10D2 
Abbrev: RI-A10 
1436.59 -1 28.3 373 
 
 
3.1.1  Behaviour of A10, A14 and A18 in an AC field 
Previously, it was shown that the ratio of translocation to bumping events of α-helical 
peptides could be manipulated by a combination of AC frequencies with a 60 mV DC voltage 
(Stefureac et al., 2012).  In this thesis, this observation was extended further to possibly find a 
correlation between the dipole moment and the AC voltage.  Three peptides, A10, A14 and 
A18, were tested with the help of nanopore analysis with and without the application of an AC 
field.  The dipole moment of each peptide was calculated using the Creighton formula 
(Creighton, 1993). 
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D = (Q * R) + d 
The dipole (D) of these peptides was calculated based on the shortest length (R) between 
the two elementary charges (Q) from the molecular modeling using the Spartan software and 
the dipole of an α-helix based on the number of alanines per peptide (d) (Stefureac et al., 2006).  
A10, A14, and A18 are composed by L-amino acids, and each of these peptides has two 
elementary charges.  Additionally, the charge dipole is in the same orientation as the helical 
dipole.  As seen in Table 3.1, from A10 to A18, the dipole moment increases with the increase 
of the length.  It is assumed that each peptides will behave differently in an AC filed based on 
its dipole moment and length. 
 
 
Figure 3.1 Screen shots of traces for A10. a. DC voltage at 100 mV, no AC voltage, b. AC 
voltage of 200 mV with a 10 MHz frequency, c. AC voltage of 200 mV with a 100 MHz 
frequency.  
 
For A10, the current traces are shown in Figure 3.1, covering 4 s with and without an 
applied AC voltage.  In the first panel (Figure 3.1 a) the long spikes for A10, around -65 pA, 
are a result of the peptide going through the pore (translocation events), while the short ones, 
around -20 pA, are a result of the peptide hitting the pore but not passing through (bumping 
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events).  An initial frequency of 10 MHz caused an increase in the ratio of bumping events to 
translocation events for A10, which further increased when 100 MHz was applied, as shown in 
Figure 3.1 b and c.   
These events were analyzed and are shown as blockade current histograms in Figure 3.2.   
 
 
Figure 3.2 Blockade current histograms for A10 at 100 mV DC. a. No AC, b. 10 MHz, c. 50 
MHz, d. 100 MHz, e. 500 MHz and f. 1 GHz.  
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For A10, three observations can be made after the application of the AC field.  First, the 
translocation peak shifts, from -62 pA to -54 pA, which was not a result of a conformational 
change in the pore since the open pore current remained constant.  Second, when the AC 
frequency was increased from 10 MHz to 1 GHz, the percentage of translocation events 
decreased from 83% to 65%, respectively.  This phenomenon was also observed previously at 
60 mV when the percentage of translocations dropped from 62% at 10 MHz to 40 % at 500 
MHz (Stefureac et al., 2012).  And third, when frequencies of 50 MHz or higher were applied, 
an intermediate peak appeared at -33 pA which was attributed to intercalation events.  It is 
suggested that when the peptide enters the pore, the AC field causes it to oscillate perpendicular 
to the pore vestibule prevented it from crossing the pore.   
The blockade histograms for A14 at 100 mV DC as shown in Figure 3.3, are similar to 
A10 at the same voltage, as shown in Figure 3.2.  The nanopore study of A14 at 100 mV DC 
and with a 200 mV AC field with frequencies in the range 10 MHz - 1 GHz is shown in Figure. 
3.3.  A14 has a single peak at -64 pA (Stefureac et al., 2006).  Similarly to A10, with the 
application of an AC frequency, a major shift of the translocation peak to -52 pA was seen 
while a second peak at -34 pA also appeared (see Figure 3.3 b).  A third small peak is present at 
-19 pA after a 50 MHz frequency was applied (see Figure 3.3 c).  Therefore, the peak at -34 pA 
should be labeled as intercalation events and the peak at -19 pA as bumping events.  Similarly 
to A10, with the increase of the frequency a significant increase of the bumping population 
from 4% at 50 MHz to 32 % at 1 GHz was observed.  Furthermore, the population of 
translocation events decreased with the increase of the frequency, from 84% at 10 MHz to 56% 
at 1 GHz (Figure 3.3 b-f).  The higher proportion of bumping events of A14 compare to A10 is 
thought to be due to A14 having a higher dipole moment which will cause a faster oscillation in 
an AC field and thus more bumping into the pore.  
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Figure. 3.3 Blockade current histograms for A14 at 100 mV DC with: a. No AC, b. 10 
MHz, c. 50 MHz, d. 100 MHz, e. 500 MHz and f. 1 GHz.  
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Figure 3.4 shows current blockade histograms for A14 results at 140 mV DC with and 
without the applied AC field.  With no applied AC voltage a broad translocation peak of 72% is 
present at -82 pA with a smaller intercalation peak at -52 pA (Figure 3.4 a).  When an AC 
voltage of 10 MHz was applied, the translocation peak disappeared whereas the intercalation 
peak shifted to -58 pA (Figure 3.4 b).  Additionally, a bumping peak appeared at -35 pA.  The 
profile of the events doesn't change with increasing AC frequencies, as seen from the 
percentages of intercalation and bumping events in Table 3.2.  A similar behaviour was 
observed for A10 at a 140 mV DC voltage.  We assume that a combination of a high DC 
voltage (140 mV) with an AC field has no significant effects on the oscillation of the peptide 
regardless of the AC frequency.   
  
  
 
Figure 3.4 Blockade Current histograms for A14 at 140 mV DC with: a. No AC and b. 10 
MHz.   
 
The largest α-helical peptide analyzed in an AC field was A18.  First, with no AC voltage 
applied there are only translocation events centered at -66 pA, but with the application of an AC 
field with a frequency of 10 MHz a second peak emerges at -45 pA (see Figure 3.5 b).  The 
blockade current of this peak is not large enough to be qualified as translocation events or small 
enough to indicate bumping.  Thus, the peak at -45 pA is probably due to intercalation.  With 
the increase of the frequency to 50 MHz a third peak appeared at -27 pA due to bumping 
events, in addition to a shoulder on the translocation peak at -73 pA.  A possible reason for the 
shoulder at -65 pA (Figure 3.5 c) is due to translocation of A18 as would be observed in the 
absence of an AC field.  Consistent with this hypothesis is the 0.29 ms duration of these events, 
a. b. 
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as shown in Figure 3.6 which is similar to the duration in the absence of an AC field (Stefureac 
et al., 2006).  In contrast, the very sharp peak at -73 pA is probably due to a bent structural 
conformation, a model for which will be presented in the Discussion.  Despite an increase in 
frequency, there were no further notable changes in the event profiles (Figure 3.5 c-f).   
 
 
 
Figure 3.5 Blockade current histograms for A18 at 100 mV DC. a. No AC, b. 10 MHz, c. 50 
MHz, d. 100 MHz, e. 500 MHz and f. 1 GHz.  
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Figure 3.6 Time histogram of the shoulder events for A18 at 100 mV DC with 50 MHz AC. 
 
To elucidate the changes in the blockade currents for A18 starting at 50 MHz, the 
blockade times for the translocation events of A18 at 60 mV, 100 mV, and 140 mV were 
measured as shown in Figure 3.7.  The fit to a single exponential is reasonable at 60 and 140 
mV, but it is clear that the time at 100 mV is significantly longer (see Figure 3.7 b).  The results 
are summarized in Figure 3.8, where the increase of the translocation time for A18 at 100 mV is 
clearly observed at 50 MHz and 500 MHz. 
 
 
 
Figure 3.7 Time histograms of translocation events for A18 at 50 MHz AC and DC voltages 
of 60, 100 and 140 mV.  
 
It is reasonable to assume that peptides with larger dipole moments are effected more by 
the AC field.  It appears that as the AC frequency increases so does the proportion of bumping 
events.  This observation is consistent with the results in Table 3.2.   
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Table 3.2 Summary of the percentages of translocation, intercalation and bumping events 
for A10, A14 and A18 with 60, 100 and 140 mV DC and 10 MHz to 1 GHz AC. (The error 
estimated for the percentage of events is ±10 %) 
 
AC 
Freq. 
(MHz) 
Peptid
e 
60 mV 100 mV 140 mV 
Trans 
Event 
(%) 
Inter 
Event 
(%) 
Bump 
Event 
(%) 
Trans 
Event 
(%) 
Inter 
Event 
(%) 
Bum 
Event 
(%) 
Trans 
Event 
(%) 
Inter 
Event 
(%) 
Bum 
Event 
(%) 
No AC 
A10 100 - - 97 - 2 80 19 - 
A14 100 - - 100 - - 72 27 - 
A18 100 - - 93 - - 92 - 7 
10 
A10 88 -  11 83 15 - - 55 45 
A14 70 - 29 84 16 - - 53 46 
A18 55 39 4 79 20 - 75 11 13 
50 
A10 45 - 54 71 18 10 - 54 45 
A14 70 - 29 80 15 4 - 48 51 
A18 50 49 - 43 26 8 69 9 21 
100 
A10 58 - 41 82 4 12 - 53 47 
A14 54 - 45 72 15 12 - 40 59 
A18 61 38 - 46 28 5 65 10 24 
500 
A10 30 - 69 71 13 14 - 60 39 
A14 47 - 52 70 14 15 - 44 55 
A18 57 42 - 47 30 5 57 9 33 
1000 
A10 60 - 39 65 16 19 - 58 41 
A14 65 - 34 56 10 32 - 39 60 
A18 60 39 - 49 22 9 55 12 32 
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Figure 3.8 Event times as a function of the DC voltage for a. A10, d. A14 and g. A18 with 
no AC frequency applied; b. A10, e. A14 and h. A18 with 50 MHz AC; and c. A10, f. A14 and 
i. A18 with 500 MHz AC.  
 
A10, A14 and A18 were studied at DC voltage offsets at 60, 100 and 140 mV (see Table 
3.2).  The blockade times are summarized in Figure 3.8.  Without an applied AC field, the time 
for translocation decreased with voltage and increased with the length of the peptide, as 
expected.  In all cases, the bumping or intercalation events were much faster.  The addition of 
an AC field did little to change this pattern for A10 and A14, but for A18, at both 50 and 500 
MHz, the time of the events reached a maximum at 100 mV.  In the absence of an AC field, the 
value of T at 100 mV was about 0.40 ms but at 50 and 500 MHZ, it was 1.55 ms and 1.25 ms, 
respectively.  At 60 mV and in the absence of an AC field, T is 0.55 ms, but at a frequency of 
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50 MHz, it decreased to 0.28 ms.  Therefore, an AC field of 50 MHz can dramatically decrease 
or increase the event time depending on the DC voltage.   
 
3.1.2  Behaviour of RI-A10 in an AC field 
A retro-inverse peptide of A10 was studied as well.  RI-A10 is an α-helix as well but is 
composed of D-amino acids and it has a larger dipole moment than A10 due to having three 
negative charges in the C-terminus (see Table 3.1).  The dipole of the helix remains in the same 
direction as the direction of the charge dipole.  Current traces are shown in Figure 3.9, covering 
16 s for RI-A10 with and without an applied AC voltage.   
 
 
 
Figure 3.9 Screen shots of traces for RI-A10. a. DC voltage at 100 mV, no AC voltage, b. 
AC voltage of 200 mV with a 10 MHz frequency, c. AC voltage of 200 mV with a 100 MHz 
frequency.  
  
For the RI peptide (Figure 3.9 a), in comparison to A10, the current trace was different.  
The translocation events for RI-A10 were around -60 pA and the bumping events around -25 
pA.  Even in the absence of an AC voltage, the frequency of events for RI-A10 was lower than 
for A10.  In the other two panels in Figure 3.9, an AC field was applied with a constant 
amplitude of 200 mV and two different frequencies.  When an AC voltage was applied at a 10 
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MHz frequency, the RI-A10 was prevented from translocating.  Short bumping events are 
evident around -30 pA.  Even at 100 MHz, bumping events constitute most of the current trace 
for RI-A10.  These events were analyzed and are shown as blockade current histograms in 
Figure 3.10.  In contrast to A10, the blockade current histograms for RI-A10 are simple and 
showed that the proportion of translocation was reduced to less than 5% at all frequencies.  
 
 
Figure 3.10 Blockade current histograms for RI-A10 at 100 mV DC. a. No AC, b. 10 MHz, 
c. 50 MHz, d. 100 MHz, e. 500 MHz and f. 1 GHz.  
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This behaviour is presumed to be due to the larger dipole moment, which will cause the 
RI-A10 to oscillate faster.  Additionally, the highly charged C-terminus, which enters the pore 
first, will be greatly affected by the AC field and it is assumed to make it more difficult for RI-
A10 to orient itself into the pore vestibule and translocate.  We assume that this could be a 
possible explanation for the drastic increase of the bumping events with the application of an 
AC field compared to A10.  
 
3.1.2.1  Equimolar mixture of A10 and RI-A10 
Superposing an AC field onto a standard nanopore DC current may be of practical use in 
discriminating a molecular mixture.  A10 and RI-A10 have similar molecular properties but 
they produce very different blockade current profiles when AC frequencies are applied (see 
Figure 3.2 and 3.10).  An equimolar mixture of the two peptides, as seen from the current traces 
in Figure 3.11, was initially analyzed without an AC frequency, which gave a broad 
translocation peak at -59 pA and a minor bumping peak at -28 pA (see Figure 3.12 a).   
 
 
Figure 3.11 Screen shots of traces for the equimolar mixture of A10 and RI-A10; a. DC 
voltage at 100 mV with no AC voltage, b. AC voltage of 200 mV with a 10 MHz frequency, 
and c. AC voltage of 200 mV with a 100 MHz frequency.  
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Figure 3.12 Blockade Current histograms for a mixture of A10 and RI-A10 at 100 mV DC 
for no AC, 10 MHz and 100 MHz applied. a., b. and c. are values from the experiment; d., e. 
and f. were calculated by adding the individual histograms.  
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The calculated blockade current histogram also give a broad translocation peak at -60 pA 
but the bumping peak is significantly smaller at about 3% (see Figure 3.5 d).  There may be a 
small degree of interference between the two peptides, which causes a higher percentage of 
bumping events (Figure 3.11 a).  The addition of an AC field at 10 and 100 MHZ, respectively, 
increased the proportion of bumping events because as expected, the RI-A10 is prevented from 
translocating (see Figure 3.10 and Figure 3.12 b and c).  There is a good fit of the two blockade 
current histograms, the calculated and the experimental, especially at 100 MHz (see Figure 3.12 
c and f). 
 
3.2  Nanopore analysis of two ssDNA, d18 and oligo-dT20 
Nanopores were initially used to detect single-stranded DNA so the effect of an AC field 
was considered interesting.  The experiment was conducted on two separate strands, d18 and 
dT20 at 1 μM concentration, in 1 M KCl + 10 mM KPi buffer at pH 7.8.   
  
d18: ATT ACC ACT TCT AGG ATA 
 
poly-dT20: TTT TTT TTT TTT TTT TTT TT  
 
Surprisingly, as shown in the current traces covering 16 s for each strand, the event 
frequency is very different for the two strands: d18 has 0.68 events sec
-1
 whereas dT20 is much 
faster with 6.75 events sec
-1
.  As seen in Figure 3.13 a, the long spikes for d18, around -85 pA, 
are due to the DNA strand translocating while the short ones, around -40 pA, are due to the 
strand bumping into the pore.  For the dT20 strand, the translocation events are around -80 pA 
and the bumping events around -34 pA. 
 
 
 
Figure 3.13 Current traces for single stranded DNA fragments a. d18 and b. dT20 at a DC 
field of 100 mV.  
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These events were analyzed and converted to blockade current histograms in Figure 3.14 
for d18 and Figure 3.15 for dT20.   
 
 
Figure 3.14 Blockade current histograms for single stranded DNA d18 at 100 mV DC. a. No 
AC, b. 10 MHz, c. 50 MHz, d. 100 MHz, e. 500 MHz and f. 1 GHz. 
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Figure 3.15 Blockade current histograms for single stranded DNA oligo-dT20 at 100 mV 
DC. a. No AC, b. 10 MHz, c. 50 MHz, d. 100 MHz, e. 500 MHz and f. 1 GHz. 
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For d18, with no AC field, there was a translocation peak at -85 pA and a bumping peak 
at -40 pA with similar event frequencies.  At 10 MHz AC, the translocation peak shifted to -80 
pA and also decreases in proportion from 49 % to 25%.  Only small changes to the histograms 
were observed as the frequency increased (see Figure 3.14 c-f).  
For dT20, the blockade current histograms are complicated; even without the application 
of an AC field, the translocation peak is divided into two peaks at -83 pA and -73 pA (Figure 
3.15 a).  At all AC frequencies, the ratio of translocation is reduced while the ratio of the 
bumping peak increased.  As shown in Figure 3.15 b, there is a major translocation peak at -75 
pA and a bumping peak at -30 pA, with a small shoulder at -44 pA.  Starting at 50 MHz, the 
translocation events have a small shoulder at -89 pA, which doesn't change even at 1 GHz.  The 
bumping peak is either split into two peaks upon application of an AC field or it becomes very 
broad (e.g. at 100 MHz in Figure 3.15 d).  It is assumed that oligo-dT20 enters the pore from 
both ends, 5' end and the 3' end, as seen previously in the literature (Chen and Li, 2007).  This 
might be a possible explanation why there are two bumping and translocation peaks for oligo-
dT20.  A detailed illustration of these observations will be presented in the Discussion. 
The blockade time of the translocation events was calculated for both strands at a 100 mV 
DC in the absence of an AC field, as shown in Figure 3.16.  It is necessary to indicate that the 
events of dT20 at the -73 pA peak were not included in the calculation of the final translocation 
time, as shown in Figure 3.16 b.  Even though the translocation events have different blockade 
current profiles, they appear to have similar blockade times. 
 
 
 
Figure 3.16 Time histograms of translocation events for single stranded DNA a. d18 and b. 
dT20 at 100 mV DC.  
60 
 
3.3  Alpha-Synuclein 
AS is a peptide of 140 amino acids, which is intrinsically disordered under most 
conditions.  The C-terminus has a net charge of −12 while the N-terminus has a net charge of 
+4 and the entire peptide has a final net charge of -9.  It is electrophoretically driven through 
the pore from the C-terminus under standard conditions (Tavassoly et al., 2014b).  Most 
random conformations of AS are expected to have very large dipole moments and, thus, it was 
of interest to analyze the effect of an added AC field. 
 
3.3.1  Nanopore analysis and voltage studies of Alpha-Synuclein 
AS was studied previously by standard nanopore analysis (Madampage et al., 2012).  The 
protein was analyzed in an aqueous solution of 10 mM HEPES buffer pH 7.8, which included 1 
mM EDTA on the cis side to chelate metals that might be present in the solution (Krasniqi and 
Lee, 2012).  Earlier, it was shown that the protein has a major translocation peak at -85 pA and 
a small bumping peak at -26 pA (Madampage et al., 2012).  A voltage study was conducted at 
60, 80, 100, 120 and 140 mV DC to show the effect of the DC field in the events profiles of AS. 
The results are shown in Figure 3.17 with the calculated times in Table 3.3.   
 
 
Figure 3.17 Blockade current histograms for AS at a. 60 mV, b. 80 mV, c. 100 mV, d. 120 
mV and e. 140 mV 
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When the DC voltage was increased from 60 mV to 80 mV, both the percentage and the 
duration of translocation events increased (Figure 3.17 a and b).  At 60 mV DC, the event 
frequency was very low.  Two broad peaks were observed: a major bumping peak of 74% at -
24 pA and a small translocation peak of 25% at 50 pA.  At 80 mV, the translocation peak was 
narrower and increased significantly to 52%.  The maximum translocation events occurred at 
100 mV (Figure 3.17 c).   
As the DC voltage increased to 120 mV, the population of the translocation events 
decreased slightly to 68% while the time also decreased (see Table 3.3).  At 140 mV, the ionic 
current constantly dropped due to the blockage of the pore with AS, and the frequency of events 
was very fast (see Figure 3.18 a).  At this high voltage, the translocation peak decreases further 
to 50% with a blockade time at 0.70 ms.  Additionally, a small but wide bumping peak occurred 
at -40 pA (47%).  Thus, the effect of voltage on the time of the translocation events is 
complicated and anomalous for the lowest and the highest DC voltages.   
 
 
 
Figure 3.18 Screen shots of traces for AS at a DC voltage at 140 mV. a. no AC voltage; b. 
AC voltage with a 100 MHz frequency, c. AC voltage with a 1 GHz frequency. 
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Table 3.3 T values of AS at 60, 80, 100, 120 and 140 mV DC voltage. (The error estimated 
for T is ±10%) 
 
 Time of Events (ms) of AS 
DC Voltage (mV) Translocations Bumping 
60 0.41 0.07 
80 0.82 0.08 
100 0.52 0.05 
120 0.47 0.11 
140 0.70 0.14 
 
3.3.2  Behaviour of Alpha-Synuclein in an AC field 
As seen from Figure 3.17 c and 3.19 a, in the absence of an AC field with a 100 mV DC 
the blockade current histogram resembled the results from a previous study (Madampage et al., 
2012).  However, as the AC frequency is increased so did the population of the bumping events 
(see Figure 3.19).  When an AC field of 200 mV at 100 MHz was applied, the number of 
translocation events dropped to 35% while the number of bumping events proportionally 
increased.  As the AC frequency increased to 1 GHz, about 73% of the events are related to 
bumping.   
AS was also analyzed at 60 and 140 mV DC, but for simplicity, the events blockade 
current for bumping (Bump), intercalation (Inter) and translocation (Trans) peaks are 
summarized in Table 3.4 below. 
At 60 mV DC without an AC voltage, the blockade histograms for AS showed two 
Gaussian peaks: a small peak at -50 pA that was due to translocation and a large peak at -24 pA 
that was due to bumping events (Figure 3.18 a).  With the application of an AC field, at a 10 
MHz frequency, the ratio of translocation events dropped from 25% to 12%.  Additionally, at 
10 MHz, a third small peak appeared which was assumed to be intercalation events.  With an 
increase of the AC frequency to 50 MHz, a minor increase in the number of translocation 
events to 15% was observed, which further increased to 17% at 100 MHz.  However, when the 
AC frequency was increased to 1 GHz, the bumping population also increased, whereas the 
translocation peak decreased and remained at 13%. 
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Figure 3.19 Blockade current histograms for AS at 100 mV DC. a. No AC, b. 10 MHz, c. 
50 MHz, d. 100 MHz, e. 500 MHz and f. 1 GHz.  
 
At the highest DC voltage of 140 mV, the behaviour of AS was complicated mostly due 
to the many drops in the ionic current, as seen in Figure 3.18.  At the first application of an AC 
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field there is an increase in the percentage of bumping events from 51 to 75%.  The blockade 
histograms of AS at 140 mV showed an initial decrease of the proportion of translocation 
events from 10 to 100 MHz followed by a steady increase back to 77% until 1 GHz, as seen in 
Table 3.4.  The fluctuation of the proportion of the translocation events at 140 mV DC suggests 
that many factors are involved.  
 
Table 3.4 Summary of the percentages of translocation, intercalation and bumping events 
for AS with 60, 100 and 140 mV DC amplitudes and 10 MHz to 1 GHz AC frequencies. (The 
error estimated for the percentages of events is ±10 %) 
 
AC Freq. 
(MHz) 
60 mV 100 mV 140 mV 
Trans 
Event 
(%) 
Inter 
Event 
(%) 
Bump 
Event 
(%) 
Trans 
Event 
(%) 
Inter 
Event 
(%) 
Bump 
Event 
(%) 
Trans 
Event 
(%) 
Inter 
Event 
(%) 
Bump 
Event 
(%) 
No AC 25  -  74 73 - 11 51  -  48 
10 12 12 74 42 - 52 75 - 24 
50 15 11 72 53 - 41 57 - 12 
100 17 6 75 35 - 57 28  - 71 
500 13 9 76 27 - 65 59 - 40 
1000 13 6 79 15 - 73 77 - 22 
 
3.3.3  Domains of Alpha-Synuclein in an AC field 
The three domains of AS were studied under the same conditions as previously published 
(Tavassoly et al., 2014a).  The blockade current histogram of the N-terminus, as seen in Figure 
3.20 a, has a single Gaussian peak at -30 pA due to bumping events.  The N-terminus is 
positively charged (+4) and as a consequence, it will be very difficult to orientate towards the 
pore and translocate through.  Conversely, the C-terminus has a -12 charge and as a result, it 
will translocate easily through the pore as seen in Figure 3.21 a.  The blockade current 
histogram has a large and wide translocation peak at -69 pA and a fairly small bumping peak at 
-30 pA.  The ΔNAC with no AC field has two peaks, a large peak at -86 pA due to translocation 
and a smaller one at -27 pA due to bumping (see Figure 2.22 a).  The domains were then tested 
in the AC voltage with an initial DC voltage of 100 mV.  
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Figure 3.20 Blockade current histograms for the N-terminus of AS (1-60) at 100 mV DC. a. 
No AC, b. 10 MHz, c. 50 MHz, d. 100 MHz, e. 500 MHz and f. 1 GHz. 
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Figure 3.21 Blockade current histograms for the C-terminus of AS (96-140) at 100 mV DC. 
a. No AC, b. 10 MHz, c. 50 MHz, d. 100 MHz, e. 500 MHz and f. 1 GHz. 
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Figure 3.22 Blockade current histograms for ΔNAC at 100 mV DC. a. No AC, b. 10 MHz, 
c. 50 MHz, d. 100 MHz, e. 500 MHz and f. 1 GHz. 
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For the N-terminus, there are few consequences after application of an AC field.  As 
shown in Figure 3.20 b, the bumping peak shifted to -26 pA after a frequency of 10 MHz was 
applied, as was previously observed with other peptides.  However, the application of higher 
frequencies has little effect mostly due to the positive charge which prevent the N-terminus 
from entering the pore initially.  
For the C-terminus domain, with the application of an AC field at a frequency of 10 MHz, 
the large translocation peak disappeared, as illustrated in Figure 3.21 b.  There is a small 
disperse translocation peak at 50 MHz, which changed little as the AC frequency was 
increased.  We assume that because of the large negative charge, the C-terminus is oscillating 
fast and thus is prevented from translocating. 
With the application of the AC field, ΔNAC behaved as expected for a peptide with a 
negative C-terminus and/or with a large dipole moment.  The proportion of bumping events 
increased with the increase of the AC frequency.  The values of T are summarized in Table 3.5.   
The time of translocation events for the ΔNAC decreased significantly after the application of 
an AC frequency of 10 MHz from 1.23 ms to 0.64 ms.  The translocation time decreases further 
at 50 MHz to 0.36 ms.  At 100 and 500 MHz very few translocation events were observed, but 
a small peak at -92 pA appeared at 1 GHz with blockade time significantly smaller at 0.11 ms. 
 
Table 3.5 Time of ΔNAC at 100 mV DC with AC frequencies from 10 MHz to 1 GHz. (The 
error estimated for T is ±10 %) 
 
  
Time of Events (ms) 
Domain 
Frequency 
(MHz) 
Translocations Bumping 
ΔNAC 
No AC 1.23 0.05 
10 0.64 0.06 
50 0.36 0.04 
100 - 0.06 
500 - 0.08 
1000 0.11 0.05 
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3.4  Analysis of Alpha-Synuclein and Drug complexes in the AC field 
Nanopore analysis with an AC field may be useful for probing the conformational states 
of AS which are induced by drugs (Kakish et al., 2015b; Shim et al., 2009; Tavassoly et al., 
2014b).  Seven drugs were chosen to be tested in an AC setup as shown in Figure 3.24.  These 
drugs were chosen based on their neuroprotective or neurotoxic role.  This separation based on 
their role in preventing further neuronal degeneration or causing Parkinson-like symptoms, is 
due to the new conformation AS adopts when the drug is bound to it.  Previous results showed 
that drugs like S-1-aminoindane, 3-methoxytyramine, caffeine and (-)-nicotine bind to both the 
N- and C-termini and form a loop conformation (Kakish et al., 2015b; Tavassoly et al., 2014a).  
This loop conformation blocks the NAC region from future aggregation, which later will 
prevent the formation of the LBs (Kakish et al., 2015a).  (+)-Amphetamine binds very tightly to 
the N-terminus forming a knot conformation, which leaves the NAC region ready for 
fibrillization (Kakish et al., 2015a).  Other drugs like metformin and cocaine were chosen to be 
studied in an AC field based on previous binding sites.  Cocaine binds to the NAC region of AS 
and metformin binds to the C-terminus.  A control was conducted with the A10 peptide, one of 
the α-helical peptides mentioned previously, with S-1-aminoindan to show that the drug does 
not interact with either the pore or the membrane of the nanopore analysis setup.  
 
 
 
Figure 3.23 Blockade current histogram of A10 with S-1-Aminoindan at 100 mV DC. 
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Their behaviour in an AC field would benefit biochemists and drug designers as both 
these drugs have been shown to alter the induction of PD.  Long term users of cocaine develop 
Parkinson-like symptoms, whereas diabetes patients who take metformin have shown decreased 
signs of PD or neuronal degeneration, which leads one to believe that this drug could be 
neuroprotective (Kakish et al., 2015a).  All the drugs have similar binding constants, therefore 
differences in conformation and possible stripping is probably due to either the charge or the 
position where they bind in the protein.  
 
 
 
Figure 3.24 Structure of a. S-1-aminoindane, b. 3-methoxytyramine, c. metformin, d. 
caffeine, e. (-)-nicotine, f. (+)-amphetamine and g. cocaine. The nomenclature concerning 
stereoisomers conforms to the published literature, i.e. S, (-) and (+).   
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3.4.1  S-1-Aminoindan 
The AS-drug complex with S-1-aminoindan was analyzed and the blockade current 
histograms are shown in Figure 3.25. 
 
 
 
Figure 3.25 Blockade current histograms for AS with S-1-Aminoindan [1:10] at 100 mV 
DC. a. No AC, b. 10 MHz, c. 50 MHz, d. 100 MHz, e. 500 MHz and f. 1 GHz. 
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The blockade histograms for S-1-aminoindan in the absence of an AC field demonstrate 
that the majority of events are related to translocation, as observed previously (Kakish et al., 
2015b).  With the application of an AC voltage at a frequency of 10 MHz, the translocation 
peak remained broad but decreased to 40%.  The translocation peak stayed at the same 
blockade current between this frequency and 50 MHz.  Interestingly, the time of the 
translocation events increased significantly from 0.24 ms with no AC to 0.63 ms at 10 MHz, as 
seen in Table 3.7.  Conversely, the proportion of bumping events increased significantly from 
18% with no AC to 58% at 10 MHz and to 72% at 50 MHz (see Figure 3.25 b and c).  At 100 
MHz, the blockade current resembled the blockade current histogram of AS at 100 MHz (see 
Figure 3.19 d).  The translocation peak increased to 30%, but remained broad, while the time of 
the translocation events also increased to 1.17 ms.  However, at 500 MHz and 1 GHz, the 
translocation peak shifted to -84 pA, which was similar to AS at these frequencies (see Figure 
3.19 e and f).  At 500 MHz, the time of translocation events decreased to 0.51 ms and to 0.33 
ms at 1 GHz.  The increase of the blockade current of the translocation events to -84 pA 
suggests that the drug might be stripped off the protein due to the high AC frequencies, a model 
for which will be presented in the Discussion.  
 
Table 3.6 Time of S-1-aminoindan events at 100 mV DC with AC frequencies from 10 MHz 
to 1 GHz. (The error estimated for T is ±10 %) 
 
  
Time of Events (ms) 
Drug 
Frequency 
(MHz) 
Translocations Bumping 
S-1-Aminoindan 
No AC 0.24 0.07 
10 0.62 0.16 
50 0.69 0.14 
100 1.17 0.13 
500 0.51 0.07 
1000 0.33 0.07 
 
3.4.2  3-Methoxytyramine 
For 3-methoxytyramine (3-MT), in the absence of an AC field, the blockade current 
histogram shows a single Gaussian peak at -37 pA (see Figure 3.25 a).  In the presence of an 
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AC field, the proportion of translocation events increased with an increase of the AC frequency.  
This is the first time that such an effect of an AC field was observed. 
  
 
 
Figure 3.26 Blockade current histograms for AS with 3-Methoxytyramine [1:10] at 100 mV 
DC. a. No AC, b. 10 MHz, c. 50 MHz, d. 100 MHz, e. 500 MHz and f. 1 GHz. 
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With an AC field at a frequency of 10 MHz, a second very broad peak appeared at -72 pA 
due to translocation. In agreement with this assumption was the 0.45 ms duration of these 
events.  At 50 MHz, a third peak emerges at -62 pA, which is thought to be due to intercalation 
events and the once broad translocation peak consolidates at -80 pA. The T values of the peaks 
at -62 pA and -80 pA are respectively 0.17 and 0.55 ms, which is in agreement with 
intercalation and translocation events, respectively.  With a further increase of the AC 
frequency, the proportion of translocation events also increased from 12% at 50 MHz to 20% at 
1 GHz.  The blockade current of these events increased to -85 pA at 100 MHz and remained att 
his value between 500 MHz and 1 GHz, with a minor change of 1 pA.  These values are similar 
to the blockade histograms of AS alone, especially at 1 GHz as seen in Figure 3.19 f.  As seen 
in the case of S-1-aminoindan, the time of translocation events increased significantly at 100 
MHz.  This is a second example of possible drug stripping, i.e. the AC field causes the drug-
protein complex to dissociate.  
 
Table 3.7 Time of 3-methoxytyramine events at 100 mV DC with AC frequencies from 10 
MHz to 1 GHz. (The error estimated for T is ±10 %) 
 
  
Time of Events (ms) 
Drug 
Frequency 
(MHz) 
Translocations Intercalation Bumping 
3-Methoxytyramine 
No AC  -   -  0.07 
10 0.45  -  0.13 
50 0.55 0.17 0.10 
100 1.12 0.20 0.09 
500 0.75 0.17 0.10 
1000 0.49 0.17 0.11 
 
3.4.3  Caffeine 
Caffeine has been thoroughly studied previously because of its neuroprotective role in PD 
so consequently it was studied in an AC field (Tavassoly et al., 2014a).  Figure 3.27 shows the 
blockade current histograms of AS in the presence of 10 μM caffeine.  As previously shown, 
caffeine causes a shift in the AS translocation peak from -86 pA to a lower current at -78 pA, 
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but with only a small change in the ratio of events (see Figure 3.27 a).  The T value of the 
translocation events is 0.54 ms. 
 
 
 
Figure 3.27 Blockade current histograms for AS with Caffeine [1:10] at 100 mV DC. a. No 
AC, b. 10 MHz, c. 50 MHz, d. 100 MHz, e. 500 MHz and f. 1 GHz. 
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With the application of an AC field of 10 MHz, the translocation peak shifted back to -84 
pA, similar to the blockade histogram of AS, but the bumping peak was slightly broader (see 
Figure 3.19 b).  Also at 10 MHz the percentage of bumping events increased significantly to 
41% (see Figure 3.27 b).  At 50 MHz, the bumping peak decreased in population to 18% but 
increased at 100 MHz to 34% (see Figure 3.27 c and d).  The time of translocation events, as 
seen in Table 3.8, decreased from 0.39 ms at 10 MHz to 0.23 ms at 100 MHz.  From 100 MHz 
to 1 GHz there are few distinct changes.  It appears that the blockade current histograms of 
caffeine, after the application of an AC frequency, resembled those of AS.  The only exception 
was that the proportion of bumping events was smaller.  Caffeine is another drug that forms a 
complex with AS which dissociates in an AC field. 
 
Table 3.8 Time of caffeine events at 100 mV DC with AC frequencies from 10 MHz to 1 
GHz. (The error estimated for T is ±10 %) 
 
  
Time of Events (ms) 
Drug 
Frequency 
(MHz) 
Translocations Bumping 
Caffeine 
No AC 0.56 0.10 
10 0.39 0.06 
50 0.26 0.03 
100 0.23 0.03 
500 0.30 0.03 
1000 0.48 0.08 
 
 
3.4.4  (-)-Nicotine 
It was previously shown that the (-)-nicotine isomer caused a large shift in the 
translocation peak of AS to a lower current of -66 pA with a smaller bumping peak with a 
population of 6% (Tavassoly et al., 2014a).  However, with the application of an AC field, the 
ratio of bumping increased significantly to 42% at 10 MHz (see Figure 3.28 b).  Similarly to 
caffeine, the blockade current translocation peak increases to -80 pA at 10 MHz.  With the 
increase of the AC frequency to 100 MHz, the blockade current of the translocation peak 
increased to -84 pA and remained roughly constant between 10 MHz and 1 GHz, as seen in the 
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case of AS (see Figure 3.28 d-f and Figure 3.19).  In addition, an increase in the proportion of 
bumping events was observed with the increase of the AC frequency.  The blockade time of the 
translocation events appeared to decrease as the AC frequency was increased, as seen in Table 
3.9.  Interestingly, the translocation time increased significantly at 100 MHz, as was observed 
in the case of S-1-aminoindan and 3-methoxytyramine.  The nicotine complex represents 
another example of possible drug stripping by the application of an AC field. 
  
Table 3.9 Time of (-)-nicotine events at 100 mV DC with AC frequencies from 10 MHz to 
1 GHz. (The error estimated for T is ±10 %) 
 
  
Time of Events (ms) 
Drug 
Frequency 
(MHz) 
Translocations Bumping 
(-)-Nicotine 
No AC 0.48 0.06 
10 0.42 0.07 
50 0.50 0.11 
100 0.60 0.14 
500 0.49 0.10 
1000 0.42 0.08 
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Figure 3.28 Blockade current histograms for AS with (-)-Nicotine [1:10] at 100 mV DC. a. 
No AC, b. 10 MHz, c. 50 MHz, d. 100 MHz, e. 500 MHz and f. 1 GHz. 
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3.4.5  Metformin 
Metformin, a drug used to treat type 2 diabetes patients, was studied in an AC field as 
illustrated in Figure 3.29. 
 
 
 
Figure 3.29 Blockade current histograms for AS with Metformin [1:10] at 100 mV DC. a. 
No AC, b. 10 MHz, c. 50 MHz, d. 100 MHz, e. 500 MHz and f. 1 GHz. 
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10 μM metformin caused a shift in the AS translocation peak to -63 pA, which is 
indicative of good binding to the protein (Kakish et al., 2015a).  Two observations can be made 
after the application of an AC field.  The application of a 10 MHz AC frequency caused the 
translocation peak to shift back to the original blockade of the AS control, at -85 pA, and 
remain approximately at the same blockade intensity at higher frequencies (see Figure 3.29 b 
and Figure 3.19).  The second observation for this drug was that the bumping events intensity 
remained roughly constant at all AC frequencies, with percentages between 50% and 60%, 
which was similar to AS alone.  In particular, for high frequencies such as 100 and 500 MHz, 
the blockade current histograms of metformin and AS were similar.  As seen in Table 3.10, the 
time of the translocation events increased significantly after the application of an AC field, 
from 0.13 ms to 0.51 ms at 50 MHz.  Surprisingly, in the case of metformin, the time decreases 
to 0.36 ms at 100 MHz, to further increase to 0.49 ms at 1 GHz.  Based on the shift of the 
current of the translocation peak to -85 pA, similar to the peak of AS alone, it seems reasonable 
to assume that the drug might be stripped from the protein as an AC field is applied.  
 
Table 3.10 Time of metformin events at 100 mV DC with AC frequencies from 10 MHz to 
1 GHz. (The error estimated for T is ±10 %) 
 
  
Time of Events (ms) 
Drug 
Frequency 
(MHz) 
Translocations Bumping 
Metformin 
No AC 0.20 0.07 
10 0.40 0.06 
50 0.51 0.06 
100 0.36 0.06 
500 0.44 0.05 
1000 0.49 0.06 
 
 
3.4.6  (+)-Amphetamine 
It was previously shown that (+)-amphetamine isomer binds to AS and increased the ratio 
of bumping events (Kakish et al., 2015a).   
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Figure 3.30 Blockade current histograms for AS with (+)-Amphetamine [1:10] at 100 mV 
DC. a. No AC, b. 10 MHz, c. 50 MHz, d. 100 MHz, e. 500 MHz and f. 1 GHz. 
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The translocation peak didn't shift from the original AS blockade current but decreased in 
proportion (see Figure 3.30 a).  With the application of an AC voltage at a frequency of 10 
MHz, the translocation population decreased by 6%, whereas the proportion of bumping events 
didn't change (see Figure 3.30 b).  There are only small changes at higher frequencies (see 
Figure 3.30 c-f).  Compared to just AS (see Figure 3.19), the blockade histograms of 
amphetamine at such high frequencies were very different, especially at 1 GHz.  At this 
frequency, the ratio of the translocation events for amphetamine is twice the ratio of 
translocation events of AS alone. 
The lack of change in the blockade current of the translocation events, as well as the 
constant ratio of these events during all the AC frequencies, suggests that the drug might not be 
stripped off the protein due to an AC field.  However, the drug-protein complex is assumed to 
oscillate in the AC field as a single entity.  
 
Table 3.11 Time of (+)-amphetamine events at 100 mV DC with AC frequencies from 10 
MHz to 1 GHz. (The error estimated for T is ±10 %) 
 
  
Time of Events (ms) 
Drug 
Frequency 
(MHz) 
Translocations Bumping 
(+)-Amphetamine 
No AC 0.46 0.02 
10 0.25 0.08 
50 0.39 0.06 
100 0.37 0.07 
500 0.38 0.06 
1000 0.24 0.05 
 
 
3.4.7  Cocaine 
The final drug to be studied in an AC field was cocaine as shown in Figure 3.31.  As seen 
previously, without the presence of an AC field, cocaine exhibited a small translocation peak at 
-84 pA and a large bumping peak at -28 pA (Kakish et al., 2015a).  
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Figure 3.31 Blockade current histograms for AS with Cocaine [1:10] at 100 mV DC. a. No 
AC, b. 10 MHz, c. 50 MHz, d. 100 MHz, e. 500 MHz and f. 1 GHz. 
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After applying an AC voltage with a 10 MHz frequency, the proportion of translocation 
events increased significantly to 44% (see Figure 3.31 b).  At 50 MHz the translocation peak 
decreased back to 22% and further dropped to 18% at 100 MHz (Figure 3.31 c-d).  However, 
the blockade time of translocation increased to 0.48 ms at 50 MHz but dropped at 100 MHz to 
0.37 ms (see Table 3.11).  Nevertheless, the ratio of translocation increased again at 500 MHz 
and further at 1 GHz (see Figure 3.31 e-f), while the time decreased to 0.30 ms at 500 MHz and 
again at 1 GHz.  
Similar to amphetamine, cocaine’s blockade current histograms are very different from 
the histograms of AS alone but it is difficult to conclude that stripping is occurring. 
 
Table 3.12 Time of cocaine events at 100 mV DC with AC frequencies from 10 MHz to 1 
GHz. (The error estimated for T is ±10 %) 
 
  
Time of Events (ms) 
Drug 
Frequency 
(MHz) 
Translocations Bumping 
Cocaine 
No AC 0.40 0.03 
10 0.44 0.09 
50 0.48 0.07 
100 0.37 0.07 
500 0.30 0.06 
1000 0.43 0.06 
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4. DISCUSSION 
 
4.1 Introducing an AC field in standard nanopore analysis 
The work of this thesis builds upon the initial observation of Radu Stefureac who showed 
that superimposing an AC field modulated the translocation of peptides (Stefureac et al., 2012).  
It was concluded that an oscillating electric field could interact with a peptide or protein to alter 
the interaction with the pore compared to a DC field.  Others have also used AC fields in 
nanopore analysis to study the flow of ions through the pore.  For example, in 2010, the AC 
field was used to observe the translocation of a DNA hairpin loop with a polydeoxyadenosine 
into the α-HML pore (Lathrop et al., 2010).  The idea of this experiment was to trap the DNA 
hairpin inside the pore using an initial DC voltage; once the DNA hairpin was blocked inside 
the pore vestibule the DC voltage was turned off and an AC voltage with amplitudes in the 
range of 20 to 250 mV and frequencies from 60 to 200 kHz was applied to let it diffuse from 
the pore.  Additionally, two protein pores, α-HML and Alamethicin (ALA), were studied in the 
AC field to understand how their ionic flow was altered by frequencies between 1 MHz and 1 
GHz (Sujatha et al., 2010).  It was shown that the ionic flow can be altered by applying the 
different AC voltages and frequencies.  As well, it was shown that electric field stress could 
alter the conformation of Αβ peptides and lead to loss of secondary structure in the α-helical 
region of the β-chain of insulin (Budi et al., 2005; Toschi et al., 2009).   
However, the primary conclusion of Stefureac et al. was that the AC field interacted with 
the dipole of the peptide and that peptides could be discriminated based on differences in dipole 
moment.  The results in this thesis strongly support this hypothesis.  First, the superposition of 
an AC field improved our understanding of the effect of the dipole moment on the translocation 
of some analytes.  Peptides with larger dipole moments are thought to oscillate faster, causing 
more bumping into the pore, as in the case of RI-A10.  This technique may also find 
applications where increased discrimination is required between a mixture of related molecules.  
Finally, the superposition of an AC field will facilitate the understanding of the many 
conformational states of intrinsically disordered proteins such as AS and it may be useful for 
probing the additional conformational states of AS which are induced by drugs.  
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4.2 Behaviour of alpha-helical peptides in an AC field 
Originally, it was suggested that small peptides, which have small dipole moments, would 
rotate quickly in a DC voltage.  This rotation will lead to restriction of translocation events for 
these peptides when it comes to orienting correctly into the vestibule and translocating through 
the α-HML pore.  Conversely, for long peptides with large dipole moments, the rotation would 
be restricted and thus, it would be easier for the peptides to translocate (Stefureac et al., 2006).  
The superposition of an AC field on a constant DC voltage during nanopore analysis caused 
large changes to the event profiles.  These changes include: (a) An increase in the proportion of 
bumping events for peptides with large dipole moments; (b) The appearance of intercalation 
events and (c) Changes to the time of translocation events.  The effect is mostly due to the 
interaction between the AC field and the dipole of the molecule and thus, molecules with 
different dipole moments can be individually manipulated by appropriate adjustments to the DC 
voltage and AC frequency.  In other words, the molecules can be made to dance to an electronic 
tune. 
 
4.2.1 Differentiating peptides based on their dipole moment  
Initially, A10, A14 and A18 were studied at DC voltages of 60, 100 and 140 mV with and 
without an AC field, as seen summarized in Table 3.2.  At a DC voltage of 100 mV, the AC 
field has only a small effect on A10 peptide whereas a DC voltage of 60 mV, previously 
reported, caused a large increase in the proportion of the bumping peak (Stefureac et al., 2012).  
The histograms of A14, at all the three DC voltages, were very similar to A10. 
As previously noticed, there are three consequences to the application of an AC field for 
A10.  First the translocation peak shifts to a lower current.  A possible explanation for this 
observation was that the AC field allows the K
+
 and Cl
-
 ions to move around the peptide more 
easily.  Second, the increase of the AC frequency decreased the proportion of translocation 
events.  Such an effect was modest compared to that previously reported for 60 mV DC.  It 
seems likely that as the DC voltage increases, the AC field has a larger effect on the oscillation 
of the peptide as it approaches the entrance to the pore.  Thus, it is assumed that the peptide will 
bump into the pore more and therefore will have fewer translocation events.  Lastly, at an AC 
frequency of 50 MHz, a third peak appears due to intercalation events.  It seems possible that as 
the molecule enters the vestibule of the pore, the AC field causes it to rotate so that it is 
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perpendicular to the lumen of the pore and cannot make any further progress (see Figure 1.3).  
When the AC field reverses, it will rotate in the opposite direction and then be ejected from the 
pore.  Conversely, the interrelation of the AC frequency with the DC voltage was difficult to 
explain.  At high DC voltages, for A10 and A14, the blockade histograms did not change with 
the increase of the AC frequency; this led us to believe that the peptide itself doesn't undergo 
significant conformational changes with the increase of the AC frequency at 140 mV DC.  
For RI-A10 it is hypothesized that the larger dipole moment of this peptide (see Table 
3.1), is the main reason why RI-A10 is bumping into the pore at a greater rate than A10, even 
though they have the same length.  Additionally, for RI-A10, the helix dipole is in the same 
direction as the charge dipole with the addition of one more negative charge is at the C-
terminus.  The C-terminus, which is the side the peptide will enter the pore first, will have three 
negative charges, and the Fmoc group is now to the rear of the peptide (Krasniqi et al., 2012).  
Compared to A10, these two differences allow easy access to the vestibule of the pore but not 
the lumen, therefore, RI-A10 is prevented from translocating.   
We assume that, based on the behaviour of the four peptides in an AC field, as the dipole 
moment increases so does the ratio of bumping events.  Additionally, the increase of the AC 
frequency will lead to a decrease of the translocation events, as well as an increase in the 
proportion of the bumping and intercalation events. 
 
4.2.1.1 Behaviour of a large alpha-helical peptide in an AC field 
For A18 at 100 mV DC with the application of an AC frequency, as seen in Figure 3.8, 
the proportion of translocation events was reduced while the bumping peak increased.  These 
changes are thought to be due to fast oscillation of the strand in the presence of an AC field.  
The appearance of a shoulder, at about -65 pA, on the translocation events at 50 MHz was very 
interesting.  These events are thought to be due to the translocation of A18 as would be 
observed in the absence of an AC field.  Interestingly, for the first time, it was observed that the 
current blockade of translocation events increased with the increase of the AC frequency. 
Initially, the translocation peak at -66 pA with no AC field, increased to -68 pA at 10 MHz and 
to -73 pA from 50 MHz to 1 GHz.   
As mentioned, the very sharp peak at -73 pA is probably due to a bent conformation, as 
shown in Figure 4.1.  It is assumed that the peptide enters the pore lumen, the AC field bends 
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the α-helix so that part of the peptide remains in the pore vestibule, because of the length of the 
peptide.  At some point, the peptide will re-orient and continue to translocate but the blockade 
current will be slightly larger and the overall time for the event will be increased considerably, 
as seen in Figure 4.1 b.  This putative bent conformation did not occur at 60 mV or at 140 mV, 
based on the open pore current of the α-HML.  It didn't occur as well for A10 or A14 because 
these peptides are shorter and have a smaller dipole moment.  This could be the reason why the 
AC field is insufficient to cause conformational changes. 
 
 
 
Figure 4.1 a. Normal approach of the peptide as trying to enter the pore vestibule. b. Peptide 
bends due to the force from the AC field. c. The peptide reforms an alpha-helix and continue 
translocating. 
 
4.2.2 Discrimination of molecular mixtures with the aid of an AC field 
This technique may also be applied to the discrimination of molecular mixtures.  In this 
case, A10 and RI-A10 have very similar properties even to the extent that the antibodies raised 
against RI-A10 will bind to A10 and their individual blockade current profiles overlap (see 
Figure 3.2 a and Figure 3.3 a) (Krasniqi et al., 2012; Stefureac et al., 2012).  
An equimolar mixture of the two peptides was analyzed with and without an AC field.  
Without the application of an AC field, the blockade histogram gave rise to a broad 
translocation peak at -59 pA and a minor bumping peak (see Figure 3.5 a).  Comparing the 
experimental histogram with the calculated one (see Figure 3.5 d), it is clear that the bumping 
peak is much smaller in the calculated histogram.  The reason for the high ratio of bumping 
events in the experimental histogram may be due to interference between the two peptides as 
they approach the pore.  The addition of an AC field at either 10 MHz or 100 MHz increases 
the proportion of bumping events for the experimental histograms as expected since the 
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translocation of RI-A10 is prevented.  Additionally, there is a good fit with the calculated 
blockade histograms for both frequencies.  To conclude, the addition of an AC field allows the 
analysis of A10 even in the presence of a related peptide. 
 
4.3 Behaviour of d18 and oligo-dT20 in an AC field 
Surprisingly, it was observed that at the same concentration of 1 μM, the two different 
ssDNAs have very different event frequencies (see Figure 3.12).  The similar time of the 
translocation events for both strands at 100 mV DC without the application of an AC field is an 
indication that both strands interact similarly with the pore.  d18 has a similar behaviour to the 
previously studied peptides, e.g. A10 and A14, in that the percentage of translocation decreases 
with the increase of the AC frequency.  Conversely, the dT20 behaviour is more complex.  It 
was previously shown that oligo-dT forms an ideal chain due to the weak assembly of thymine 
bases, compared to the stable secondary structure of oligo-dA or oligo-dC (Egli and Saenger, 
2013).  Since there is little secondary structure, it is easy for the dT20 to orient in the pore in 
the DC field and translocate compared to d18.  A possible explanation for the two translocation 
and bumping peaks observed in Figure 3.14, is that this strand is threading through the pore in 
two directions, either from the 5' end and/or the 3' end (see Figure 4.2).  It was previously 
observed that ssDNA could enter the α-HML pore from its 3’ and 5’ end, although the ratio of 
the events from the entrance of ssDNA from its 5' end is lower than the ratio of the events from 
the entrance from the 3' end (Chen and Li, 2007).  
  
 
 
Figure 4.2 Oligo-dT entering the α-HML pore from its a. 5' end and b. 3' end. 
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4.4  Alpha-Synuclein and fragments 
4.4.1 Voltage studies and Nanopore analysis 
It was previously reported that an increase of the DC voltage led to a decrease of the 
duration of the translocation events (Madampage et al., 2012).  This observation was confirmed 
in this thesis when the DC voltage was increased from 80 mV to 120 mV.  The time of 
translocation events dropped from 0.82 ms at 80 mV to 0.52 ms at 100 mV.  As well, at 120 
mV the duration of these events decreased to 0.47 ms. Thus, when increasing the 
electrophoretic voltage, the dipole moment will aid AS to orient into the pore vestibule and 
make translocating easier.  Interestingly the same relationship between time and voltage was 
not observed in the case of 60 and 140 mV.  At 60 mV there are very few translocation events 
due to the small electrophoretic voltage.  Similarly, at 140 mV there are also very few 
translocation events due to the blockage of the pore, as seen from the several droppings in the 
ionic current in Figure 3.17.  This may explain why the translocation times at these voltages are 
anomalous. 
 
4.4.2 Behaviour of Alpha-Synuclein and its domains in an AC field 
AS was studied at DC voltages between 60, 100 and 140 mV.  With the application of an 
AC field, AS behaves differently for each DC amplitude.  
At 60 mV DC, the proportion of translocation events decreased after the application of an 
AC frequency at 10 MHz.  The ratio of the translocation peak remains fairly constant at around 
15%.  It appears that at 60 mV DC, in the presence of an AC field, AS oscillates fast preventing 
the protein from entering the pore.  At 100 mV DC in the absence of an AC field, the majority 
of the events were translocation events (Madampage et al., 2012).  With the application of an 
AC field at a frequency of 10 MHz, the ratio of bumping events increased to 52%.  As 
previously noted, the bumping peak increased with a further increase of the AC frequency, until 
1 GHz, where the ratio of bumping peak is 73%.  Conversely, at 140 mV DC with the 
application of an AC field, the bumping peak decreased to 24% at 10 MHz and further to 12% 
at 50 MHz.  However, a frequency of 100 MHz causes AS to oscillate faster and it bumps more 
into the pore vestibule; this frequency seems to prevent the protein from entering the pore.  
With a further increase of the AC frequency, the bumping peak decreased once more. 
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The AS domains (N-terminus, C-terminus, and ΔNAC) were also studied in an AC field, 
as their behaviour in a DC field is well known (Tavassoly et al., 2014a).  After the application 
of an AC field, the blockade histograms for the N-terminus and C-terminus were very similar.  
After a 10 MHz AC frequency was applied, the N-terminal's bumping peak increased to 73% 
and remained constant through all the other AC frequencies.  The C-terminus at 10 MHz lost 
the broad translocation peak and the bumping peak increased to 64% and remained constant 
throughout.  Having a large negative charge, the C-terminus presumably oscillates fast in an 
AC field, and is thus prevented from entering the pore.  For the ΔNAC, the proportion of 
translocation events decreased with the increase of the AC frequency until 100 MHz, where the 
peptide was prevented completely from translocating.  The same event profile was observed at 
500 MHz, but a small peak at -92 pA appeared at 1 GHz.  The ΔNAC behaved as expected for a 
peptide with a negative C-terminus and a large dipole moment. 
 
4.5  Protein-drug complexes 
4.5.1  Drugs studied in an AC field 
 
Table 4.1 shows the binding constants and probable binding site for seven drugs which 
induce conformational changes of AS (Kakish et al., 2015a; Kakish et al., 2015b; Tavassoly et 
al., 2014a).  These drugs were shown not to interact with the α-HML pore. 
 
 
Table 4.1 ITC results of the seven drugs that bind AS (Kakish et al., 2015a; Kakish et al., 
2015b; Tavassoly et al., 2014a). 
 
Compound Ka (M
-1
) Binding site 
S-1-Aminoindan 3 * 10
5 
N- and C-term 
3-Methoxytyramine 3.2 * 10
6 
N- and C-term 
Caffeine 7 * 10
5 
N- and C-term 
(-)-Nicotine 1 * 10
6 
N- and C-term 
Metformin 9 * 10
6 
2 binding sites C-term 
(+)-Amphetamine 6.8 * 10
5 
N-terminus 
Cocaine 7.8 * 10
5
 NAC-region 
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4.5.1.1 Drugs that are possibly stripped from AS by an AC field  
From the results it appears that S-1-aminoindan, 3-methoxytyramine, caffeine, (-)-
nicotine and metformin at high AC frequencies, were assumed to strip from the binding site of 
the protein (see Figure 4.3).  ITC and nanopore analysis results suggests that these drugs bind to 
both the N- and C-termini of AS, except for metformin, which appears to bind to two sites in 
the C-terminus. 
 
 
 
Figure 4.3 Model of drug striping from AS in the presence of an AC field. a. The drug 
binds the N- and the C-terminus forming b. a loop conformation. c. The N- and the C-termini 
move in the opposite direction, thus stripping the drug from the protein.  
 
A loop conformation blocks the aggregation of the ΔNAC, which is linked directly to AS 
fibrillization.  In the presence of an AC field, the complex is expected to oscillate.  In this loop 
conformation, the two charged ends are very close, and therefore, an AC frequency will force 
them to move in opposite directions.  Thus, it is assumed that an AC field with an initial 
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frequency of 10 MHz (e.g. caffeine and (-)-nicotine); or higher frequencies such as 500 MHz or 
1 GHz (e.g. S-1-aminoindan and 3-methoxytyramine), will disassociate the drug from its 
binding site.  Conversely, for metformin, it is assumed that, because the drug binds to the C-
terminus, which is highly negatively charged and the drug is a dication, the application of an 
AC it is hypothesized to lead to stripping. 
Additionally, based on their weak binding constant, there is AS-free in the solution (free 
AS: 30-10% based on the Ka: 10
5
-10
6
 M
-1
).  It is thought that with the application of an AC 
field the pore selectivity will change, giving priority to the free form of AS rather the AS-drug 
complex.  This is observed very clearly in the case of (-)-nicotine knowing that its binding 
constants is in 10
5
 range.  Additionally, caffeine behaves in a very similar manner to (-)-
nicotine, even though its binding constant is slightly higher, in the 10
6
 range.  As mentioned 
above, we don't see the passage of free AS for neither 3-methoxytyramine and S-1-aminoindan 
until higher AC frequencies are applied.  It must be assumed that there is a relationship between 
the AC frequency and the binding constant that will allow the pore to be more selective towards 
the free AS in the solution or to cause a stripping of the drug.  
   
4.5.1.2 Drugs that oscillate with the AS complex in an AC field 
The other drugs, (+)-amphetamine and cocaine form a compact conformation with AS.  
These drugs are neurotoxic based on their ability to induce PD-like symptoms.  Amphetamine 
binds to AS at the N-terminus based on previous nanopore analysis and ITC results (Kakish et 
al., 2015a).  This conformation does not involve the C-terminus and in an AC field, there may 
be little effect on the drug binding.  It is assumed that the AS-amphetamine complex oscillates 
in the presence of an AC field as an entity, based on the blockade current histograms, which 
show no significant changes throughout all the AC frequencies (see Figure 3.29).  Additionally, 
cocaine was studied with AS WT and its domains in nanopore analysis and ITC (Kakish et al., 
2015a).  It is thought to bind to the NAC region of AS and it is assumed that this complex 
oscillates in an AC field as an entity as well, without any sign of drug stripping.  
Based on the pore selectivity hypothesis, cocaine and metformin have weak binding 
constants as well, but there seem to be no sign of the passage of AS-alone.  It appears that the 
complex is translocating through the pore as an entity. 
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Figure 4.4 The AS-amphetamine complex and its behaviour in the presence of an AC 
field. a. Initially the drug binds the N-terminus and b. forms a knot conformation. c. which then 
oscillates in the AC field.  
 
4.6  Future directions 
Nanopore analysis with an AC field may be useful for probing the conformational states 
of AS induced by other drugs and metal ions (Kakish et al., 2015a; Kakish et al., 2015b; Shim 
et al., 2009; Tavassoly et al., 2014a; Tavassoly et al., 2014b).   
Recently, it was demonstrated that solid-state pores on a silicon nitride membrane can be 
used to detect AS and the several intermediate states of partially unfolded oligomers, due to AS 
aggregation (Hu et al., 2016).  One innovation for this new solid-state pore technique was 
coating of the membrane by Polysorbate 20 (Tween 20), which gave a smooth membrane 
surface and allows AS to translocate easily.  Major problems observed with the solid-state pores 
such as dropping of the ionic current due to clogging, and the constant fluctuation of current 
traces were solved with the application of the Tween 20 layer.  This technique was successful 
because it was able to identify four types of AS oligomers.  We assume that an AC voltage 
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could be superimposed on this new solid-state pore and thus help in probing further 
conformational states of different analytes, such as AS multimers and/or AS-drug complexes.  
Additionally, fluorescent labeling methods could be used in nanopore analysis to further 
observe the stripping of the drug from AS.  A similar technique has been used before, 
especially for labeling DNA strands to observe their translocation in solid–state pores  (Chen et 
al., 2004; McNally et al., 2010; Soni et al., 2010).  With the aid of fluorescent labeling it was 
possible to view in real-time the passage of the strand through the pore.  This technique could 
help witness the actual moment of the drug being stripped from AS due to the AC field.  For 
instance, metformin, buformin or phenformin are some of the drugs previously studied in 
nanopore analysis (Kakish et al., 2015a; Schweiger et al., 2012).  These drugs would be good 
candidates to be studied in the AC field, as their DC behaviour is well known.  We suppose that 
using fluorescent labeling it will be possible to monitor the activity of the pore in real-time.  
However, this technique is difficult to achieve and requires very expensive equipment. 
Finally, it would of a great interest to observe the behaviour of protein-protein complexes 
in an AC field.  Proteins with different charges, which form a complex, are expected to behave 
differently in an AC field.  It was shown that polar amino acids and accumulation of positive or 
negative charges over the protein-protein border causes a destabilizing effect in the electrostatic 
characteristics of certain protein-protein complexes (Sheinerman et al., 2000).  We assume that, 
under an AC field, it could possible to observe dissociation in the case of protein-protein 
complexes, as their fast oscillation in the AC filed will pull them apart.   
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